ONTOLOGY REPORT - ANNOTATIONS
| Term: | all-trans-retinoic acid |
|
| Accession: | CHEBI:15367
|
browse the term
|
| Definition: | A retinoic acid in which all four exocyclic double bonds have E- (trans-) geometry. |
| Synonyms: | exact_synonym: | (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid |
| | related_synonym: | (all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid; 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ECL); AGN 100335; Acide retinoique (French) (DSL); C20H28O2; CC(\\C=C\\C1=C(C)CCCC1(C)C)=C/C=C/C(C)=C/C(O)=O; InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+; InChIKey=SHGAZHPCJJPHSC-YCNIQYBTSA-N; RETINOIC ACID; Renova; Retin-A; Retisol-A; Ro 1-5488; Stieva-A; Tretin M; Tretinoine (French) (EINECS); Vesanoid; Vitamin A acid; all-(E)-Retinoic acid; all-trans-Tretinoin; all-trans-Vitamin A acid; all-trans-Vitamin A1 acid; all-trans-beta-Retinoic acid; beta-Retinoic acid; trans-Retinoic acid; tretinoin |
| | alt_id: | CHEBI:45376; CHEBI:8815 |
| | xref_casrn: | 302-79-4 |
| | xref: | Beilstein:2057223 "Beilstein Registry Number"; ChEMBL:102208 "ChEMBL COMPOUND"; ChemIDplus:302-79-4 "CAS Registry Number"; CiteXplore:11073974 "PubMed citation"; CiteXplore:11214352 "PubMed citation"; CiteXplore:11332619 "PubMed citation"; CiteXplore:11343416 "PubMed citation"; CiteXplore:11437362 "PubMed citation"; CiteXplore:11556813 "PubMed citation"; CiteXplore:11722649 "PubMed citation"; CiteXplore:11896294 "PubMed citation"; CiteXplore:11904404 "PubMed citation"; CiteXplore:14581379 "PubMed citation"; CiteXplore:14605492 "PubMed citation"; CiteXplore:14627725 "PubMed citation"; CiteXplore:14704332 "PubMed citation"; CiteXplore:14705145 "PubMed citation"; CiteXplore:14978018 "PubMed citation"; CiteXplore:15194426 "PubMed citation"; CiteXplore:15318809 "PubMed citation"; CiteXplore:15327395 "PubMed citation"; CiteXplore:15359008 "PubMed citation"; CiteXplore:15376324 "PubMed citation"; CiteXplore:15476854 "PubMed citation"; CiteXplore:15537748 "PubMed citation"; CiteXplore:15539337 "PubMed citation"; CiteXplore:15675886 "PubMed citation"; CiteXplore:15839997 "PubMed citation"; CiteXplore:16569247 "PubMed citation"; CiteXplore:16685080 "PubMed citation"; CiteXplore:16688769 "PubMed citation"; CiteXplore:16720557 "PubMed citation"; CiteXplore:16819260 "PubMed citation"; CiteXplore:16847436 "PubMed citation"; CiteXplore:16920920 "PubMed citation"; CiteXplore:17073551 "PubMed citation"; CiteXplore:17166212 "PubMed citation"; CiteXplore:17204142 "PubMed citation"; CiteXplore:18052213 "PubMed citation"; CiteXplore:18085670 "PubMed citation"; CiteXplore:18162363 "PubMed citation"; CiteXplore:18183617 "PubMed citation"; CiteXplore:18318655 "PubMed citation"; CiteXplore:18322276 "PubMed citation"; CiteXplore:18400206 "PubMed citation"; CiteXplore:18404486 "PubMed citation"; CiteXplore:18440196 "PubMed citation"; CiteXplore:18678272 "PubMed citation"; CiteXplore:18819820 "PubMed citation"; CiteXplore:18977311 "PubMed citation"; CiteXplore:19112091 "PubMed citation"; CiteXplore:19144697 "PubMed citation"; CiteXplore:19427305 "PubMed citation"; CiteXplore:19587328 "PubMed citation"; CiteXplore:19597529 "PubMed citation"; CiteXplore:19814868 "PubMed citation"; CiteXplore:19841174 "PubMed citation"; CiteXplore:21898109 "PubMed citation"; CiteXplore:21924320 "PubMed citation"; CiteXplore:21993673 "PubMed citation"; CiteXplore:22134377 "PubMed citation"; CiteXplore:22177959 "PubMed citation"; CiteXplore:22180426 "PubMed citation"; CiteXplore:22244299 "PubMed citation"; CiteXplore:22261335 "PubMed citation"; CiteXplore:22428994 "PubMed citation"; CiteXplore:22514600 "PubMed citation"; CiteXplore:22532966 "PubMed citation"; CiteXplore:22534100 "PubMed citation"; CiteXplore:22538278 "PubMed citation"; CiteXplore:22741806 "PubMed citation"; DrugBank:DB00755 "DrugBank"; HMDB:HMDB01852 "HMDB"; KEGG COMPOUND:302-79-4 "CAS Registry Number"; KEGG COMPOUND:C00777 "KEGG COMPOUND"; KEGG DRUG:D00094 "KEGG DRUG"; LIPID MAPS:LMPR01090019 "LIPID MAPS instance" |
| | xref_mesh: | MESH:D014212 |
| | xref: | PDBeChem:REA "PDBeChem"; Reaxys:2057223 "Reaxys Registry Number"; Wikipedia:Tretinoin "Wikipedia" |
| | cyclic_relationship: | is_conjugate_acid_of CHEBI:35291 |
|
|
all-trans-retinoic acid
|
| G |
Aard |
alanine and arginine rich domain containing protein |
|
increases expression |
ISO |
7 |
88,346,189 |
88,351,030 |
RGD:6480464 |
CTD |
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
multiple interactions |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
increases expression |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abcb10 |
ATP-binding cassette, subfamily B (MDR/TAP), member 10 |
|
decreases expression |
ISO |
19 |
54,151,400 |
54,181,495 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
multiple interactions |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
increases acetylation |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
increases expression |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
increases expression |
ISO |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
decreases expression |
ISO |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Abcc6 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 6 |
|
increases expression |
ISO |
1 |
96,448,588 |
96,524,655 |
RGD:6480464 |
CTD |
| G |
Abce1 |
ATP-binding cassette, subfamily E (OABP), member 1 |
|
decreases expression |
ISO |
19 |
30,093,741 |
30,118,625 |
RGD:6480464 |
CTD |
| G |
Abce1 |
ATP-binding cassette, subfamily E (OABP), member 1 |
|
multiple interactions |
ISO |
19 |
30,093,741 |
30,118,625 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
multiple interactions |
ISO |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Ago1 |
argonaute RISC catalytic component 1 |
|
increases expression |
ISO |
5 |
145,797,436 |
145,829,516 |
RGD:6480464 |
CTD |
| G |
Ahcyl2 |
adenosylhomocysteinase-like 2 |
|
increases expression |
ISO |
4 |
56,654,054 |
56,801,641 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
increases expression |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
aicda |
activation-induced cytidine deaminase |
|
increases expression |
ISO |
4 |
159,006,328 |
159,017,501 |
RGD:6480464 |
CTD |
| G |
Aimp1 |
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 |
|
increases expression |
ISO |
2 |
230,142,679 |
230,166,226 |
RGD:6480464 |
CTD |
| G |
Aip |
aryl-hydrocarbon receptor-interacting protein |
|
decreases expression |
ISO |
1 |
206,697,248 |
206,704,457 |
RGD:6480464 |
CTD |
| G |
Aip |
aryl-hydrocarbon receptor-interacting protein |
|
increases expression |
ISO |
1 |
206,697,248 |
206,704,457 |
RGD:6480464 |
CTD |
| G |
Akap12 |
A kinase (PRKA) anchor protein 12 |
|
increases expression |
ISO |
1 |
34,979,039 |
35,068,763 |
RGD:6480464 |
CTD |
| G |
Akap2 |
A kinase (PRKA) anchor protein 2 |
|
decreases expression |
ISO |
5 |
75,814,965 |
75,855,492 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases response to substance |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases activity |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Alas1 |
aminolevulinate, delta-, synthase 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
affects binding |
ISO |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
decreases expression |
ISO |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
multiple interactions |
ISO |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
decreases secretion |
ISO |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
decreases expression |
EXP |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
decreases expression |
ISO |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
decreases activity |
ISO |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
increases chemical synthesis |
ISO |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
multiple interactions |
ISO |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
increases expression |
ISO |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
increases chemical synthesis |
EXP |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Aldh1a2 |
aldehyde dehydrogenase 1 family, member A2 |
|
increases chemical synthesis |
ISO |
8 |
75,692,099 |
75,771,159 |
RGD:6480464 |
CTD |
| G |
Aldh1a2 |
aldehyde dehydrogenase 1 family, member A2 |
|
multiple interactions |
ISO |
8 |
75,692,099 |
75,771,159 |
RGD:6480464 |
CTD |
| G |
Aldh1a2 |
aldehyde dehydrogenase 1 family, member A2 |
|
affects chemical synthesis |
ISO |
8 |
75,692,099 |
75,771,159 |
RGD:6480464 |
CTD |
| G |
Aldh1a2 |
aldehyde dehydrogenase 1 family, member A2 |
|
affects chemical synthesis |
ISO |
8 |
75,692,099 |
75,771,159 |
RGD:6480464 |
CTD |
| G |
Aldh1a2 |
aldehyde dehydrogenase 1 family, member A2 |
|
increases chemical synthesis |
ISO |
8 |
75,692,099 |
75,771,159 |
RGD:6480464 |
CTD |
| G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
|
increases chemical synthesis |
ISO |
1 |
120,847,746 |
120,881,883 |
RGD:6480464 |
CTD |
| G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
|
affects chemical synthesis |
ISO |
1 |
120,847,746 |
120,881,883 |
RGD:6480464 |
CTD |
| G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
|
multiple interactions |
ISO |
1 |
120,847,746 |
120,881,883 |
RGD:6480464 |
CTD |
| G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
|
increases chemical synthesis |
ISO |
1 |
120,847,746 |
120,881,883 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
increases expression |
ISO |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
|
decreases expression |
ISO |
10 |
47,365,195 |
47,374,880 |
RGD:6480464 |
CTD |
| G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
|
decreases activity |
ISO |
10 |
47,365,195 |
47,374,880 |
RGD:6480464 |
CTD |
| G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
|
multiple interactions |
ISO |
10 |
47,365,195 |
47,374,880 |
RGD:6480464 |
CTD |
| G |
Aldh3a2 |
aldehyde dehydrogenase 3 family, member A2 |
|
increases expression |
ISO |
10 |
47,400,518 |
47,421,064 |
RGD:6480464 |
CTD |
| G |
Alox15 |
arachidonate 15-lipoxygenase |
|
affects expression |
ISO |
10 |
57,185,939 |
57,194,388 |
RGD:6480464 |
CTD |
| G |
Alox15 |
arachidonate 15-lipoxygenase |
|
multiple interactions |
ISO |
10 |
57,185,939 |
57,194,388 |
RGD:6480464 |
CTD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
increases expression |
ISO |
4 |
152,610,283 |
152,657,891 |
RGD:6480464 |
CTD |
| G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
|
increases expression |
ISO |
12 |
6,245,808 |
6,269,796 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
multiple interactions |
ISO |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
increases activity |
ISO |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
multiple interactions |
ISO |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
increases activity |
ISO |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
increases expression |
ISO |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
multiple interactions |
EXP |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
multiple interactions |
EXP |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
increases expression |
EXP |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
increases activity |
EXP |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Ambp |
alpha-1-microglobulin/bikunin precursor |
|
affects binding |
ISO |
5 |
80,119,742 |
80,129,962 |
RGD:6480464 |
CTD |
| G |
Amd1 |
adenosylmethionine decarboxylase 1 |
|
decreases expression |
ISO |
20 |
44,452,475 |
44,468,111 |
RGD:6480464 |
CTD |
| G |
Amot |
angiomotin |
|
increases expression |
ISO |
X |
33,018,434 |
33,062,515 |
RGD:6480464 |
CTD |
| G |
Amy2a3 |
amylase 2a3 |
|
decreases expression |
ISO |
2 |
209,507,212 |
209,518,455 |
RGD:6480464 |
CTD |
| G |
Anapc5 |
anaphase-promoting complex subunit 5 |
|
increases expression |
ISO |
12 |
34,850,485 |
34,884,726 |
RGD:6480464 |
CTD |
| G |
Angpt2 |
angiopoietin 2 |
|
increases expression |
ISO |
16 |
75,891,757 |
75,942,255 |
RGD:6480464 |
CTD |
| G |
Angpt2 |
angiopoietin 2 |
|
increases secretion |
ISO |
16 |
75,891,757 |
75,942,255 |
RGD:6480464 |
CTD |
| G |
Anxa1 |
annexin A1 |
|
multiple interactions |
ISO |
1 |
223,478,436 |
223,494,455 |
RGD:6480464 |
CTD |
| G |
Anxa1 |
annexin A1 |
|
increases expression |
ISO |
1 |
223,478,436 |
223,494,455 |
RGD:6480464 |
CTD |
| G |
Anxa2 |
annexin A2 |
|
decreases expression |
ISO |
8 |
73,897,618 |
73,934,041 |
RGD:6480464 |
CTD |
| G |
Arl6ip5 |
ADP-ribosylation-like factor 6 interacting protein 5 |
|
increases expression |
ISO |
4 |
131,929,503 |
131,953,033 |
RGD:6480464 |
CTD |
| G |
Arntl |
aryl hydrocarbon receptor nuclear translocator-like |
|
multiple interactions |
ISO |
1 |
171,062,181 |
171,162,426 |
RGD:6480464 |
CTD |
| G |
Arntl |
aryl hydrocarbon receptor nuclear translocator-like |
|
increases expression |
ISO |
1 |
171,062,181 |
171,162,426 |
RGD:6480464 |
CTD |
| G |
Arpc3 |
actin related protein 2/3 complex, subunit 3 |
|
increases expression |
ISO |
12 |
35,366,969 |
35,377,111 |
RGD:6480464 |
CTD |
| G |
Asf1b |
ASF1 anti-silencing function 1 homolog B (S. cerevisiae) |
|
decreases expression |
ISO |
19 |
25,867,384 |
25,881,909 |
RGD:6480464 |
CTD |
| G |
Asl |
argininosuccinate lyase |
|
increases expression |
ISO |
12 |
27,702,882 |
27,720,230 |
RGD:6480464 |
CTD |
| G |
Asna1 |
arsA arsenite transporter, ATP-binding, homolog 1 (bacterial) |
|
increases expression |
ISO |
19 |
24,786,390 |
24,794,477 |
RGD:6480464 |
CTD |
| G |
Ass1 |
argininosuccinate synthase 1 |
|
decreases expression |
ISO |
3 |
10,578,717 |
10,622,332 |
RGD:6480464 |
CTD |
| G |
Atad2 |
ATPase family, AAA domain containing 2 |
|
decreases expression |
ISO |
7 |
94,808,296 |
94,851,986 |
RGD:6480464 |
CTD |
| G |
Atf2 |
activating transcription factor 2 |
|
affects localization |
ISO |
3 |
56,403,676 |
56,496,473 |
RGD:6480464 |
CTD |
| G |
Atf6 |
activating transcription factor 6 |
|
increases expression |
ISO |
13 |
86,543,773 |
86,718,970 |
RGD:6480464 |
CTD |
| G |
Atoh1 |
atonal homolog 1 (Drosophila) |
|
increases expression |
ISO |
4 |
94,109,650 |
94,111,745 |
RGD:6480464 |
CTD |
| G |
Atp13a3 |
ATPase type 13A3 |
|
decreases expression |
ISO |
11 |
72,263,084 |
72,290,643 |
RGD:6480464 |
CTD |
| G |
Atp1b2 |
ATPase, Na+/K+ transporting, beta 2 polypeptide |
|
increases expression |
ISO |
10 |
56,418,323 |
56,424,465 |
RGD:6480464 |
CTD |
| G |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
decreases expression |
ISO |
12 |
35,266,600 |
35,316,237 |
RGD:6480464 |
CTD |
| G |
Atp6v1a |
ATPase, H+ transporting, lysosomal V1 subunit A |
|
increases expression |
ISO |
11 |
58,127,307 |
58,180,225 |
RGD:6480464 |
CTD |
| G |
Atp7a |
ATPase, Cu++ transporting, alpha polypeptide |
|
increases expression |
ISO |
X |
94,192,540 |
94,249,776 |
RGD:6480464 |
CTD |
| G |
Atpif1 |
ATPase inhibitory factor 1 |
|
multiple interactions |
ISO |
5 |
152,618,307 |
152,622,024 |
RGD:6480464 |
CTD |
| G |
Aurkaip1 |
aurora kinase A interacting protein 1 |
|
decreases expression |
ISO |
5 |
172,684,455 |
172,685,851 |
RGD:6480464 |
CTD |
| G |
Aurkb |
aurora kinase B |
|
decreases expression |
ISO |
10 |
55,798,710 |
55,804,367 |
RGD:6480464 |
CTD |
| G |
Aurkb |
aurora kinase B |
|
increases expression |
ISO |
10 |
55,798,710 |
55,804,367 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
increases expression |
ISO |
3 |
118,205,007 |
118,206,985 |
RGD:6480464 |
CTD |
| G |
B2m |
beta-2 microglobulin |
|
increases expression |
ISO |
3 |
108,927,919 |
108,932,718 |
RGD:6480464 |
CTD |
| G |
B2m |
beta-2 microglobulin |
|
increases expression |
ISO |
3 |
108,927,919 |
108,932,718 |
RGD:6480464 |
CTD |
| G |
B3gnt1 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1 |
|
decreases expression |
ISO |
1 |
207,659,039 |
207,661,261 |
RGD:6480464 |
CTD |
| G |
B3gnt2 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 |
|
decreases expression |
ISO |
14 |
103,499,471 |
103,524,296 |
RGD:6480464 |
CTD |
| G |
B4galt5 |
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 5 |
|
increases expression |
ISO |
3 |
158,440,189 |
158,449,419 |
RGD:6480464 |
CTD |
| G |
Bace1 |
beta-site APP cleaving enzyme 1 |
|
affects localization |
ISO |
8 |
48,817,824 |
48,839,681 |
RGD:6480464 |
CTD |
| G |
Bace1 |
beta-site APP cleaving enzyme 1 |
|
increases expression |
ISO |
8 |
48,817,824 |
48,839,681 |
RGD:6480464 |
CTD |
| G |
Bace1 |
beta-site APP cleaving enzyme 1 |
|
increases expression |
ISO |
8 |
48,817,824 |
48,839,681 |
RGD:6480464 |
CTD |
| G |
Bace1 |
beta-site APP cleaving enzyme 1 |
|
increases expression |
ISO |
8 |
48,817,824 |
48,839,681 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
decreases phosphorylation |
ISO |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
multiple interactions |
ISO |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
increases expression |
ISO |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Baiap2l1 |
BAI1-associated protein 2-like 1 |
|
increases expression |
ISO |
12 |
10,584,749 |
10,668,948 |
RGD:6480464 |
CTD |
| G |
Bak1 |
BCL2-antagonist/killer 1 |
|
multiple interactions |
ISO |
20 |
5,255,954 |
5,264,593 |
RGD:6480464 |
CTD |
| G |
Bak1 |
BCL2-antagonist/killer 1 |
|
increases expression |
ISO |
20 |
5,255,954 |
5,264,593 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases cleavage |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
affects localization |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bbc3 |
Bcl-2 binding component 3 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bbox1 |
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
|
increases expression |
ISO |
3 |
95,747,735 |
95,786,852 |
RGD:6480464 |
CTD |
| G |
Bcar1 |
breast cancer anti-estrogen resistance 1 |
|
increases expression |
ISO |
19 |
41,646,190 |
41,669,234 |
RGD:6480464 |
CTD |
| G |
Bccip |
BRCA2 and CDKN1A interacting protein |
|
increases expression |
ISO |
1 |
193,205,778 |
193,211,504 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases phosphorylation |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2a1 |
BCL2-related protein A1 |
|
multiple interactions |
ISO |
8 |
94,045,109 |
94,053,777 |
RGD:6480464 |
CTD |
| G |
Bcl2a1 |
BCL2-related protein A1 |
|
increases expression |
ISO |
8 |
94,045,109 |
94,053,777 |
RGD:6480464 |
CTD |
| G |
Bcl2a1 |
BCL2-related protein A1 |
|
multiple interactions |
ISO |
8 |
94,045,109 |
94,053,777 |
RGD:6480464 |
CTD |
| G |
Bmp7 |
bone morphogenetic protein 7 |
|
increases expression |
ISO |
3 |
163,723,429 |
163,799,567 |
RGD:6480464 |
CTD |
| G |
Bmpr1b |
bone morphogenetic protein receptor, type IB |
|
increases expression |
ISO |
2 |
239,727,569 |
239,767,802 |
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
multiple interactions |
ISO |
1 |
198,683,009 |
198,700,075 |
RGD:6480464 |
CTD |
| G |
Boc |
BOC cell adhesion associated, oncogene regulated |
|
increases expression |
ISO |
11 |
57,668,326 |
57,710,373 |
RGD:6480464 |
CTD |
| G |
Braf |
v-raf murine sarcoma viral oncogene homolog B1 |
|
decreases expression |
ISO |
4 |
67,117,759 |
67,243,058 |
RGD:6480464 |
CTD |
| G |
Brca1 |
breast cancer 1, early onset |
|
increases expression |
ISO |
10 |
90,513,630 |
90,572,676 |
RGD:6480464 |
CTD |
| G |
Brca1 |
breast cancer 1, early onset |
|
increases expression |
ISO |
10 |
90,513,630 |
90,572,676 |
RGD:6480464 |
CTD |
| G |
Btc |
betacellulin |
|
decreases expression |
ISO |
14 |
18,194,470 |
18,235,228 |
RGD:6480464 |
CTD |
| G |
Btg1 |
B-cell translocation gene 1, anti-proliferative |
|
increases expression |
ISO |
7 |
34,029,300 |
34,031,557 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
affects localization |
ISO |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
affects response to substance |
ISO |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
increases expression |
ISO |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
multiple interactions |
ISO |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
Btn2a2 |
butyrophilin, subfamily 2, member A2 |
|
increases expression |
ISO |
17 |
48,823,679 |
48,834,495 |
RGD:6480464 |
CTD |
| G |
Bzw1 |
basic leucine zipper and W2 domains 1 |
|
decreases expression |
ISO |
9 |
57,053,423 |
57,065,699 |
RGD:6480464 |
CTD |
| G |
Ca2 |
carbonic anhydrase 2 |
|
increases expression |
ISO |
2 |
88,077,095 |
88,092,223 |
RGD:6480464 |
CTD |
| G |
Ca2 |
carbonic anhydrase 2 |
|
increases activity |
ISO |
2 |
88,077,095 |
88,092,223 |
RGD:6480464 |
CTD |
| G |
Cacna1a |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
|
decreases expression |
ISO |
19 |
25,188,170 |
25,424,495 |
RGD:6480464 |
CTD |
| G |
Cacng5 |
calcium channel, voltage-dependent, gamma subunit 5 |
|
increases expression |
ISO |
10 |
97,300,594 |
97,309,023 |
RGD:6480464 |
CTD |
| G |
Cadm1 |
cell adhesion molecule 1 |
|
increases expression |
ISO |
8 |
50,765,645 |
51,108,962 |
RGD:6480464 |
CTD |
| G |
Camk2b |
calcium/calmodulin-dependent protein kinase II beta |
|
multiple interactions |
EXP |
14 |
86,632,686 |
86,721,281 |
RGD:6480464 |
CTD |
| G |
Camk2g |
calcium/calmodulin-dependent protein kinase II gamma |
|
multiple interactions |
ISO |
15 |
3,729,433 |
3,786,060 |
RGD:6480464 |
CTD |
| G |
Capn1 |
calpain 1, (mu/I) large subunit |
|
decreases activity |
ISO |
1 |
208,620,286 |
208,645,007 |
RGD:6480464 |
CTD |
| G |
Capn1 |
calpain 1, (mu/I) large subunit |
|
decreases expression |
ISO |
1 |
208,620,286 |
208,645,007 |
RGD:6480464 |
CTD |
| G |
Capn10 |
calpain 10 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Capn2 |
calpain 2, (m/II) large subunit |
|
multiple interactions |
ISO |
13 |
98,473,367 |
98,524,463 |
RGD:6480464 |
CTD |
| G |
Capn2 |
calpain 2, (m/II) large subunit |
|
decreases activity |
ISO |
13 |
98,473,367 |
98,524,463 |
RGD:6480464 |
CTD |
| G |
Capn2 |
calpain 2, (m/II) large subunit |
|
decreases expression |
ISO |
13 |
98,473,367 |
98,524,463 |
RGD:6480464 |
CTD |
| G |
Capza1 |
capping protein (actin filament) muscle Z-line, alpha 1 |
|
decreases expression |
ISO |
2 |
200,080,802 |
200,125,881 |
RGD:6480464 |
CTD |
| G |
Car6 |
carbonic anhydrase 6 |
|
increases expression |
ISO |
5 |
167,332,219 |
167,350,880 |
RGD:6480464 |
CTD |
| G |
Casp1 |
caspase 1 |
|
multiple interactions |
ISO |
8 |
2,027,976 |
2,036,872 |
RGD:6480464 |
CTD |
| G |
Casp12 |
caspase 12 |
|
multiple interactions |
ISO |
8 |
2,082,933 |
2,110,511 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
multiple interactions |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
multiple interactions |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
increases expression |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
multiple interactions |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases cleavage |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Cbx3 |
chromobox homolog 3 |
|
decreases expression |
ISO |
4 |
79,707,325 |
79,720,100 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
decreases expression |
ISO |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
increases expression |
ISO |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
increases expression |
ISO |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
decreases expression |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnb2 |
cyclin B2 |
|
decreases expression |
ISO |
8 |
74,892,108 |
74,906,181 |
RGD:6480464 |
CTD |
| G |
Ccnb2 |
cyclin B2 |
|
increases expression |
ISO |
8 |
74,892,108 |
74,906,181 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases response to substance |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases ubiquitination |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd2 |
cyclin D2 |
|
increases expression |
ISO |
4 |
163,523,817 |
163,546,501 |
RGD:6480464 |
CTD |
| G |
Ccnd2 |
cyclin D2 |
|
increases expression |
ISO |
4 |
163,523,817 |
163,546,501 |
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
multiple interactions |
ISO |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
multiple interactions |
ISO |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
multiple interactions |
ISO |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
decreases expression |
ISO |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
decreases expression |
ISO |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
multiple interactions |
EXP |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
increases expression |
ISO |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
decreases expression |
EXP |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccne2 |
cyclin E2 |
|
decreases expression |
ISO |
5 |
25,032,748 |
25,044,509 |
RGD:6480464 |
CTD |
| G |
Ccnh |
cyclin H |
|
multiple interactions |
ISO |
2 |
14,179,894 |
14,200,704 |
RGD:6480464 |
CTD |
| G |
Ccnh |
cyclin H |
|
decreases activity |
ISO |
2 |
14,179,894 |
14,200,704 |
RGD:6480464 |
CTD |
| G |
Ccnt1 |
cyclin T1 |
|
increases expression |
ISO |
7 |
137,288,635 |
137,314,809 |
RGD:6480464 |
CTD |
| G |
Ccr1 |
chemokine (C-C motif) receptor 1 |
|
increases expression |
ISO |
8 |
128,693,658 |
128,699,213 |
RGD:6480464 |
CTD |
| G |
Ccr2 |
chemokine (C-C motif) receptor 2 |
|
increases expression |
ISO |
8 |
128,892,784 |
128,893,905 |
RGD:6480464 |
CTD |
| G |
Ccr3 |
chemokine (C-C motif) receptor 3 |
|
increases expression |
ISO |
8 |
128,759,943 |
128,769,341 |
RGD:6480464 |
CTD |
| G |
Ccr6 |
chemokine (C-C motif) receptor 6 |
|
increases expression |
ISO |
1 |
47,115,472 |
47,139,825 |
RGD:6480464 |
CTD |
| G |
Ccrn4l |
CCR4 carbon catabolite repression 4-like (S. cerevisiae) |
|
decreases expression |
ISO |
2 |
140,120,310 |
140,140,518 |
RGD:6480464 |
CTD |
| G |
Cd14 |
CD14 molecule |
|
multiple interactions |
ISO |
18 |
29,374,593 |
29,376,190 |
RGD:6480464 |
CTD |
| G |
Cd14 |
CD14 molecule |
|
multiple interactions |
ISO |
18 |
29,374,593 |
29,376,190 |
RGD:6480464 |
CTD |
| G |
Cd14 |
CD14 molecule |
|
multiple interactions |
ISO |
18 |
29,374,593 |
29,376,190 |
RGD:6480464 |
CTD |
| G |
Cd14 |
CD14 molecule |
|
increases expression |
ISO |
18 |
29,374,593 |
29,376,190 |
RGD:6480464 |
CTD |
| G |
Cd14 |
CD14 molecule |
|
increases expression |
ISO |
18 |
29,374,593 |
29,376,190 |
RGD:6480464 |
CTD |
| G |
Cd14 |
CD14 molecule |
|
multiple interactions |
EXP |
18 |
29,374,593 |
29,376,190 |
RGD:6480464 |
CTD |
| G |
Cd1d1 |
CD1d1 molecule |
|
multiple interactions |
ISO |
2 |
179,011,165 |
179,014,672 |
RGD:6480464 |
CTD |
| G |
Cd1d1 |
CD1d1 molecule |
|
increases expression |
ISO |
2 |
179,011,165 |
179,014,672 |
RGD:6480464 |
CTD |
| G |
Cd1d1 |
CD1d1 molecule |
|
increases expression |
ISO |
2 |
179,011,165 |
179,014,672 |
RGD:6480464 |
CTD |
| G |
Cd1d1 |
CD1d1 molecule |
|
increases expression |
EXP |
2 |
179,011,165 |
179,014,672 |
RGD:6480464 |
CTD |
| G |
Cd2ap |
CD2-associated protein |
|
multiple interactions |
EXP |
9 |
13,827,015 |
13,888,338 |
RGD:6480464 |
CTD |
| G |
Cd34 |
CD34 molecule |
|
multiple interactions |
ISO |
13 |
110,877,594 |
110,896,722 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
multiple interactions |
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
increases expression |
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd37 |
CD37 molecule |
|
decreases expression |
ISO |
1 |
95,709,961 |
95,715,116 |
RGD:6480464 |
CTD |
| G |
Cd38 |
CD38 molecule |
|
multiple interactions |
ISO |
14 |
72,320,479 |
72,360,329 |
RGD:6480464 |
CTD |
| G |
Cd38 |
CD38 molecule |
|
multiple interactions |
ISO |
14 |
72,320,479 |
72,360,329 |
RGD:6480464 |
CTD |
| G |
Cd38 |
CD38 molecule |
|
increases expression |
ISO |
14 |
72,320,479 |
72,360,329 |
RGD:6480464 |
CTD |
| G |
Cd38 |
CD38 molecule |
|
increases expression |
ISO |
14 |
72,320,479 |
72,360,329 |
RGD:6480464 |
CTD |
| G |
Cd3g |
CD3 molecule, gamma |
|
increases expression |
ISO |
8 |
47,924,369 |
47,930,550 |
RGD:6480464 |
CTD |
| G |
Cd4 |
Cd4 molecule |
|
increases expression |
ISO |
4 |
160,988,512 |
161,014,038 |
RGD:6480464 |
CTD |
| G |
Cd40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
multiple interactions |
ISO |
3 |
156,092,602 |
156,107,427 |
RGD:6480464 |
CTD |
| G |
Cd40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
increases expression |
ISO |
3 |
156,092,602 |
156,107,427 |
RGD:6480464 |
CTD |
| G |
Cd40lg |
CD40 ligand |
|
multiple interactions |
ISO |
X |
141,925,019 |
141,937,183 |
RGD:6480464 |
CTD |
| G |
Cd44 |
Cd44 molecule |
|
increases expression |
ISO |
3 |
88,022,962 |
88,110,352 |
RGD:6480464 |
CTD |
| G |
Cd44 |
Cd44 molecule |
|
decreases expression |
ISO |
3 |
88,022,962 |
88,110,352 |
RGD:6480464 |
CTD |
| G |
Cd53 |
Cd53 molecule |
|
multiple interactions |
ISO |
2 |
202,186,125 |
202,234,570 |
RGD:6480464 |
CTD |
| G |
Cd53 |
Cd53 molecule |
|
increases expression |
ISO |
2 |
202,186,125 |
202,234,570 |
RGD:6480464 |
CTD |
| G |
Cd55 |
Cd55 molecule |
|
increases expression |
ISO |
13 |
43,322,246 |
43,348,334 |
RGD:6480464 |
CTD |
| G |
Cd80 |
Cd80 molecule |
|
increases expression |
ISO |
11 |
64,045,358 |
64,070,072 |
RGD:6480464 |
CTD |
| G |
Cd83 |
CD83 molecule |
|
multiple interactions |
ISO |
17 |
26,705,646 |
26,725,470 |
RGD:6480464 |
CTD |
| G |
Cd83 |
CD83 molecule |
|
increases expression |
ISO |
17 |
26,705,646 |
26,725,470 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 molecule |
|
increases expression |
ISO |
11 |
66,215,233 |
66,238,882 |
RGD:6480464 |
CTD |
| G |
Cd9 |
CD9 molecule |
|
decreases expression |
ISO |
4 |
162,279,462 |
162,312,889 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
affects localization |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
increases expression |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
increases expression |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
increases expression |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
increases phosphorylation |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
affects localization |
EXP |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
increases phosphorylation |
EXP |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
|
decreases expression |
ISO |
1 |
203,835,215 |
203,837,844 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
increases expression |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
decreases expression |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
increases expression |
ISO |
5 |
108,939,669 |
108,945,293 |
RGD:6480464 |
CTD |
| G |
Cdkn2c |
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
|
increases expression |
ISO |
5 |
131,012,524 |
131,017,679 |
RGD:6480464 |
CTD |
| G |
Cdt1 |
chromatin licensing and DNA replication factor 1 |
|
decreases expression |
ISO |
19 |
52,848,559 |
52,853,880 |
RGD:6480464 |
CTD |
| G |
Cdv3 |
carnitine deficiency-associated gene expressed in ventricle 3 homolog (mouse) |
|
increases expression |
ISO |
8 |
108,365,896 |
108,376,263 |
RGD:6480464 |
CTD |
| G |
Cdx1 |
caudal type homeo box 1 |
|
increases expression |
ISO |
18 |
56,983,284 |
57,006,721 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
multiple interactions |
ISO |
1 |
87,626,111 |
87,627,499 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
multiple interactions |
ISO |
1 |
87,626,111 |
87,627,499 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
multiple interactions |
ISO |
1 |
87,626,111 |
87,627,499 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
multiple interactions |
ISO |
1 |
87,626,111 |
87,627,499 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
increases activity |
ISO |
1 |
87,626,111 |
87,627,499 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
affects localization |
ISO |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions |
ISO |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions |
ISO |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions |
ISO |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
increases activity |
ISO |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
increases expression |
ISO |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
increases expression |
ISO |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
increases expression |
ISO |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
increases expression |
EXP |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cebpe |
CCAAT/enhancer binding protein (C/EBP), epsilon |
|
multiple interactions |
ISO |
15 |
32,787,946 |
32,789,344 |
RGD:6480464 |
CTD |
| G |
Cebpe |
CCAAT/enhancer binding protein (C/EBP), epsilon |
|
multiple interactions |
ISO |
15 |
32,787,946 |
32,789,344 |
RGD:6480464 |
CTD |
| G |
Cebpe |
CCAAT/enhancer binding protein (C/EBP), epsilon |
|
multiple interactions |
ISO |
15 |
32,787,946 |
32,789,344 |
RGD:6480464 |
CTD |
| G |
Cebpe |
CCAAT/enhancer binding protein (C/EBP), epsilon |
|
multiple interactions |
ISO |
15 |
32,787,946 |
32,789,344 |
RGD:6480464 |
CTD |
| G |
Cebpe |
CCAAT/enhancer binding protein (C/EBP), epsilon |
|
increases expression |
ISO |
15 |
32,787,946 |
32,789,344 |
RGD:6480464 |
CTD |
| G |
Cebpe |
CCAAT/enhancer binding protein (C/EBP), epsilon |
|
increases expression |
ISO |
15 |
32,787,946 |
32,789,344 |
RGD:6480464 |
CTD |
| G |
Cebpe |
CCAAT/enhancer binding protein (C/EBP), epsilon |
|
multiple interactions |
ISO |
15 |
32,787,946 |
32,789,344 |
RGD:6480464 |
CTD |
| G |
Cebpg |
CCAAT/enhancer binding protein (C/EBP), gamma |
|
decreases expression |
ISO |
1 |
87,552,695 |
87,559,447 |
RGD:6480464 |
CTD |
| G |
Cebpz |
CCAAT/enhancer binding protein zeta |
|
decreases expression |
ISO |
6 |
1,698,162 |
1,715,846 |
RGD:6480464 |
CTD |
| G |
Celf4 |
CUGBP, Elav-like family member 4 |
|
decreases expression |
ISO |
18 |
17,347,052 |
17,614,411 |
RGD:6480464 |
CTD |
| G |
Cfb |
complement factor B |
|
increases expression |
ISO |
20 |
4,072,124 |
4,077,802 |
RGD:6480464 |
CTD |
| G |
Cfl1 |
cofilin 1, non-muscle |
|
affects expression |
ISO |
1 |
208,133,876 |
208,137,408 |
RGD:6480464 |
CTD |
| G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
|
multiple interactions |
ISO |
9 |
57,309,836 |
57,356,635 |
RGD:6480464 |
CTD |
| G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
|
multiple interactions |
ISO |
9 |
57,309,836 |
57,356,635 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
decreases expression |
ISO |
4 |
43,874,852 |
44,041,870 |
RGD:6480464 |
CTD |
| G |
Chat |
choline O-acetyltransferase |
|
multiple interactions |
ISO |
16 |
7,913,026 |
7,965,985 |
RGD:6480464 |
CTD |
| G |
Chat |
choline O-acetyltransferase |
|
increases expression |
ISO |
16 |
7,913,026 |
7,965,985 |
RGD:6480464 |
CTD |
| G |
Chat |
choline O-acetyltransferase |
|
increases expression |
ISO |
16 |
7,913,026 |
7,965,985 |
RGD:6480464 |
CTD |
| G |
Chi3l1 |
chitinase 3-like 1 (cartilage glycoprotein-39) |
|
increases expression |
ISO |
13 |
47,139,658 |
47,147,591 |
RGD:6480464 |
CTD |
| G |
Chrna3 |
cholinergic receptor, nicotinic, alpha 3 (neuronal) |
|
increases expression |
ISO |
8 |
58,570,223 |
58,583,594 |
RGD:6480464 |
CTD |
| G |
Chrna3 |
cholinergic receptor, nicotinic, alpha 3 (neuronal) |
|
multiple interactions |
ISO |
8 |
58,570,223 |
58,583,594 |
RGD:6480464 |
CTD |
| G |
Chrna4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal) |
|
decreases expression |
ISO |
3 |
170,171,214 |
170,185,998 |
RGD:6480464 |
CTD |
| G |
Chrna4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal) |
|
multiple interactions |
ISO |
3 |
170,171,214 |
170,185,998 |
RGD:6480464 |
CTD |
| G |
Chrna7 |
cholinergic receptor, nicotinic, alpha 7 (neuronal) |
|
increases expression |
ISO |
1 |
117,587,580 |
117,716,267 |
RGD:6480464 |
CTD |
| G |
Chrnb2 |
cholinergic receptor, nicotinic, beta 2 (neuronal) |
|
increases expression |
ISO |
2 |
181,961,373 |
181,969,581 |
RGD:6480464 |
CTD |
| G |
Chrne |
cholinergic receptor, nicotinic, epsilon (muscle) |
|
increases expression |
ISO |
10 |
57,497,192 |
57,501,511 |
RGD:6480464 |
CTD |
| G |
Chst15 |
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15 |
|
increases expression |
ISO |
1 |
191,708,603 |
191,737,958 |
RGD:6480464 |
CTD |
| G |
Ciao1 |
cytosolic iron-sulfur protein assembly 1 |
|
decreases expression |
ISO |
3 |
114,740,676 |
114,746,203 |
RGD:6480464 |
CTD |
| G |
Cidea |
cell death-inducing DFFA-like effector a |
|
increases expression |
ISO |
18 |
63,871,538 |
63,896,975 |
RGD:6480464 |
CTD |
| G |
Ciita |
class II, major histocompatibility complex, transactivator |
|
increases expression |
ISO |
10 |
5,087,174 |
5,133,418 |
RGD:6480464 |
CTD |
| G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
increases expression |
ISO |
1 |
12,721,500 |
12,723,943 |
RGD:6480464 |
CTD |
| G |
Ckb |
creatine kinase, brain |
|
decreases expression |
ISO |
6 |
136,452,215 |
136,455,122 |
RGD:6480464 |
CTD |
| G |
Clcn4 |
chloride channel, voltage-sensitive 4 |
|
increases expression |
ISO |
X |
44,355,648 |
44,419,524 |
RGD:6480464 |
CTD |
| G |
Cldn4 |
claudin 4 |
|
increases expression |
ISO |
12 |
22,816,134 |
22,817,932 |
RGD:6480464 |
CTD |
| G |
Cldn6 |
claudin 6 |
|
increases expression |
ISO |
10 |
12,944,503 |
12,947,271 |
RGD:6480464 |
CTD |
| G |
Cldn7 |
claudin 7 |
|
increases expression |
ISO |
10 |
56,810,947 |
56,813,134 |
RGD:6480464 |
CTD |
| G |
Cox6a2 |
cytochrome c oxidase subunit VIa polypeptide 2 |
|
increases expression |
ISO |
1 |
187,464,579 |
187,465,301 |
RGD:6480464 |
CTD |
| G |
Cpe |
carboxypeptidase E |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
increases expression |
ISO |
1 |
205,852,800 |
205,912,972 |
RGD:6480464 |
CTD |
| G |
Cpt1b |
carnitine palmitoyltransferase 1b, muscle |
|
increases expression |
ISO |
7 |
127,737,129 |
127,746,179 |
RGD:6480464 |
CTD |
| G |
Cr2 |
complement component (3d/Epstein Barr virus) receptor 2 |
|
multiple interactions |
ISO |
13 |
111,078,338 |
111,113,667 |
RGD:6480464 |
CTD |
| G |
Crabp1 |
cellular retinoic acid binding protein 1 |
|
decreases response to substance |
ISO |
8 |
58,317,337 |
58,325,375 |
RGD:6480464 |
CTD |
| G |
Crabp1 |
cellular retinoic acid binding protein 1 |
|
increases expression |
ISO |
8 |
58,317,337 |
58,325,375 |
RGD:6480464 |
CTD |
| G |
Crabp1 |
cellular retinoic acid binding protein 1 |
|
increases expression |
ISO |
8 |
58,317,337 |
58,325,375 |
RGD:6480464 |
CTD |
| G |
Crabp1 |
cellular retinoic acid binding protein 1 |
|
increases expression |
ISO |
8 |
58,317,337 |
58,325,375 |
RGD:6480464 |
CTD |
| G |
Crabp1 |
cellular retinoic acid binding protein 1 |
|
affects binding |
ISO |
8 |
58,317,337 |
58,325,375 |
RGD:6480464 |
CTD |
| G |
Crabp2 |
cellular retinoic acid binding protein 2 |
|
increases response to substance |
ISO |
2 |
180,029,801 |
180,034,147 |
RGD:6480464 |
CTD |
| G |
Crabp2 |
cellular retinoic acid binding protein 2 |
|
multiple interactions |
ISO |
2 |
180,029,801 |
180,034,147 |
RGD:6480464 |
CTD |
| G |
Crabp2 |
cellular retinoic acid binding protein 2 |
|
multiple interactions |
ISO |
2 |
180,029,801 |
180,034,147 |
RGD:6480464 |
CTD |
| G |
Crabp2 |
cellular retinoic acid binding protein 2 |
|
multiple interactions |
ISO |
2 |
180,029,801 |
180,034,147 |
RGD:6480464 |
CTD |
| G |
Crabp2 |
cellular retinoic acid binding protein 2 |
|
affects binding |
ISO |
2 |
180,029,801 |
180,034,147 |
RGD:6480464 |
CTD |
| G |
Crabp2 |
cellular retinoic acid binding protein 2 |
|
multiple interactions |
ISO |
2 |
180,029,801 |
180,034,147 |
RGD:6480464 |
CTD |
| G |
Crabp2 |
cellular retinoic acid binding protein 2 |
|
increases expression |
ISO |
2 |
180,029,801 |
180,034,147 |
RGD:6480464 |
CTD |
| G |
Crabp2 |
cellular retinoic acid binding protein 2 |
|
affects expression |
ISO |
2 |
180,029,801 |
180,034,147 |
RGD:6480464 |
CTD |
| G |
Crabp2 |
cellular retinoic acid binding protein 2 |
|
affects binding |
ISO |
2 |
180,029,801 |
180,034,147 |
RGD:6480464 |
CTD |
| G |
Crabp2 |
cellular retinoic acid binding protein 2 |
|
increases expression |
ISO |
2 |
180,029,801 |
180,034,147 |
RGD:6480464 |
CTD |
| G |
Crabp2 |
cellular retinoic acid binding protein 2 |
|
increases expression |
ISO |
2 |
180,029,801 |
180,034,147 |
RGD:6480464 |
CTD |
| G |
Crabp2 |
cellular retinoic acid binding protein 2 |
|
increases expression |
EXP |
2 |
180,029,801 |
180,034,147 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
ISO |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
increases activity |
ISO |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
increases phosphorylation |
ISO |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Crebbp |
CREB binding protein |
|
multiple interactions |
ISO |
10 |
11,598,680 |
11,724,122 |
RGD:6480464 |
CTD |
| G |
Crebbp |
CREB binding protein |
|
multiple interactions |
ISO |
10 |
11,598,680 |
11,724,122 |
RGD:6480464 |
CTD |
| G |
Crebbp |
CREB binding protein |
|
multiple interactions |
ISO |
10 |
11,598,680 |
11,724,122 |
RGD:6480464 |
CTD |
| G |
Crebbp |
CREB binding protein |
|
multiple interactions |
ISO |
10 |
11,598,680 |
11,724,122 |
RGD:6480464 |
CTD |
| G |
Crebbp |
CREB binding protein |
|
multiple interactions |
ISO |
10 |
11,598,680 |
11,724,122 |
RGD:6480464 |
CTD |
| G |
Creg1 |
cellular repressor of E1A-stimulated genes 1 |
|
increases expression |
ISO |
13 |
81,491,304 |
81,503,755 |
RGD:6480464 |
CTD |
| G |
Crisp1 |
cysteine-rich secretory protein 1 |
|
decreases expression |
ISO |
9 |
16,975,151 |
17,002,149 |
RGD:6480464 |
CTD |
| G |
Crkl |
v-crk sarcoma virus CT10 oncogene homolog (avian)-like |
|
multiple interactions |
ISO |
11 |
85,520,244 |
85,554,667 |
RGD:6480464 |
CTD |
| G |
Cryab |
crystallin, alpha B |
|
increases expression |
ISO |
8 |
54,107,824 |
54,111,502 |
RGD:6480464 |
CTD |
| G |
Crygb |
crystallin, gamma B |
|
increases expression |
ISO |
9 |
63,730,906 |
63,732,966 |
RGD:6480464 |
CTD |
| G |
Crygc |
crystallin, gamma C |
|
increases expression |
ISO |
9 |
63,720,585 |
63,722,620 |
RGD:6480464 |
CTD |
| G |
Crygf |
crystallin, gamma F |
|
increases expression |
ISO |
9 |
64,679,611 |
64,681,775 |
RGD:6480464 |
CTD |
| G |
Cse1l |
CSE1 chromosome segregation 1-like (yeast) |
|
multiple interactions |
ISO |
3 |
158,061,678 |
158,100,065 |
RGD:6480464 |
CTD |
| G |
Cse1l |
CSE1 chromosome segregation 1-like (yeast) |
|
decreases expression |
ISO |
3 |
158,061,678 |
158,100,065 |
RGD:6480464 |
CTD |
| G |
Csf1r |
colony stimulating factor 1 receptor |
|
multiple interactions |
ISO |
18 |
57,080,324 |
57,107,295 |
RGD:6480464 |
CTD |
| G |
Csf1r |
colony stimulating factor 1 receptor |
|
multiple interactions |
ISO |
18 |
57,080,324 |
57,107,295 |
RGD:6480464 |
CTD |
| G |
Csf1r |
colony stimulating factor 1 receptor |
|
increases response to substance |
ISO |
18 |
57,080,324 |
57,107,295 |
RGD:6480464 |
CTD |
| G |
Csf1r |
colony stimulating factor 1 receptor |
|
multiple interactions |
ISO |
18 |
57,080,324 |
57,107,295 |
RGD:6480464 |
CTD |
| G |
Csf1r |
colony stimulating factor 1 receptor |
|
increases expression |
ISO |
18 |
57,080,324 |
57,107,295 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions |
ISO |
10 |
39,665,850 |
39,667,831 |
RGD:6480464 |
CTD |
| G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
multiple interactions |
ISO |
10 |
87,473,990 |
87,476,365 |
RGD:6480464 |
CTD |
| G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
multiple interactions |
ISO |
10 |
87,473,990 |
87,476,365 |
RGD:6480464 |
CTD |
| G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
decreases expression |
ISO |
10 |
87,473,990 |
87,476,365 |
RGD:6480464 |
CTD |
| G |
Csf3r |
colony stimulating factor 3 receptor (granulocyte) |
|
increases expression |
ISO |
5 |
145,374,596 |
145,394,045 |
RGD:6480464 |
CTD |
| G |
Csf3r |
colony stimulating factor 3 receptor (granulocyte) |
|
increases expression |
ISO |
5 |
145,374,596 |
145,394,045 |
RGD:6480464 |
CTD |
| G |
Csn3 |
casein kappa |
|
increases expression |
ISO |
14 |
21,674,805 |
21,681,360 |
RGD:6480464 |
CTD |
| G |
Csnk2b |
casein kinase 2, beta polypeptide |
|
decreases expression |
ISO |
20 |
3,764,565 |
3,768,985 |
RGD:6480464 |
CTD |
| G |
Csrp2 |
cysteine and glycine-rich protein 2 |
|
decreases expression |
ISO |
7 |
49,910,235 |
49,929,536 |
RGD:6480464 |
CTD |
| G |
Csrp3 |
cysteine and glycine-rich protein 3 (cardiac LIM protein) |
|
increases expression |
ISO |
1 |
98,601,681 |
98,611,747 |
RGD:6480464 |
CTD |
| G |
Cst6 |
cystatin E/M |
|
increases expression |
ISO |
1 |
207,991,313 |
207,993,021 |
RGD:6480464 |
CTD |
| G |
Csta |
cystatin A (stefin A) |
|
increases expression |
ISO |
11 |
66,456,248 |
66,467,253 |
RGD:6480464 |
CTD |
| G |
Ctbp2 |
C-terminal binding protein 2 |
|
decreases expression |
ISO |
1 |
192,463,615 |
192,492,935 |
RGD:6480464 |
CTD |
| G |
Ctcf |
CCCTC-binding factor (zinc finger protein) |
|
affects expression |
ISO |
19 |
35,461,942 |
35,514,934 |
RGD:6480464 |
CTD |
| G |
Ctnna1 |
catenin (cadherin-associated protein), alpha 1, 102kDa |
|
decreases expression |
ISO |
18 |
27,629,915 |
27,769,360 |
RGD:6480464 |
CTD |
| G |
Ctnna1 |
catenin (cadherin-associated protein), alpha 1, 102kDa |
|
increases expression |
ISO |
18 |
27,629,915 |
27,769,360 |
RGD:6480464 |
CTD |
| G |
Ctnna2 |
catenin (cadherin associated protein), alpha 2 |
|
affects expression |
ISO |
4 |
110,747,551 |
111,922,482 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
decreases expression |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnd1 |
catenin (cadherin associated protein), delta 1 |
|
increases expression |
ISO |
3 |
67,809,603 |
67,860,287 |
RGD:6480464 |
CTD |
| G |
Ctps |
CTP synthase |
|
decreases expression |
ISO |
5 |
141,136,686 |
141,165,817 |
RGD:6480464 |
CTD |
| G |
Ctsd |
cathepsin D |
|
increases expression |
ISO |
1 |
202,619,669 |
202,631,545 |
RGD:6480464 |
CTD |
| G |
Ctsg |
cathepsin G |
|
decreases expression |
ISO |
15 |
34,622,211 |
34,624,798 |
RGD:6480464 |
CTD |
| G |
Ctsg |
cathepsin G |
|
decreases expression |
ISO |
15 |
34,622,211 |
34,624,798 |
RGD:6480464 |
CTD |
| G |
Ctsl1 |
cathepsin L1 |
|
decreases expression |
ISO |
17 |
6,288,013 |
6,294,174 |
RGD:6480464 |
CTD |
| G |
Cubn |
cubilin (intrinsic factor-cobalamin receptor) |
|
increases expression |
ISO |
17 |
87,545,893 |
87,772,079 |
RGD:6480464 |
CTD |
| G |
Cuedc1 |
CUE domain containing 1 |
|
increases expression |
ISO |
10 |
76,467,673 |
76,488,136 |
RGD:6480464 |
CTD |
| G |
Cul4a |
cullin 4A |
|
decreases expression |
ISO |
16 |
81,242,293 |
81,279,498 |
RGD:6480464 |
CTD |
| G |
Cul5 |
cullin 5 |
|
decreases expression |
ISO |
8 |
57,080,787 |
57,132,486 |
RGD:6480464 |
CTD |
| G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
1 |
241,945,472 |
241,949,220 |
RGD:6480464 |
CTD |
| G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
1 |
241,945,472 |
241,949,220 |
RGD:6480464 |
CTD |
| G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
241,945,472 |
241,949,220 |
RGD:6480464 |
CTD |
| G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
1 |
241,945,472 |
241,949,220 |
RGD:6480464 |
CTD |
| G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
241,945,472 |
241,949,220 |
RGD:6480464 |
CTD |
| G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
1 |
241,945,472 |
241,949,220 |
RGD:6480464 |
CTD |
| G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
|
affects degradation |
ISO |
4 |
118,734,786 |
118,751,606 |
RGD:6480464 |
CTD |
| G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
|
decreases activity |
ISO |
4 |
118,734,786 |
118,751,606 |
RGD:6480464 |
CTD |
| G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
|
increases metabolic processing |
ISO |
4 |
118,734,786 |
118,751,606 |
RGD:6480464 |
CTD |
| G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
4 |
118,734,786 |
118,751,606 |
RGD:6480464 |
CTD |
| G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
|
multiple interactions |
ISO |
4 |
118,734,786 |
118,751,606 |
RGD:6480464 |
CTD |
| G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
|
multiple interactions |
ISO |
4 |
118,734,786 |
118,751,606 |
RGD:6480464 |
CTD |
| G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
4 |
118,734,786 |
118,751,606 |
RGD:6480464 |
CTD |
| G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
|
multiple interactions |
EXP |
4 |
118,734,786 |
118,751,606 |
RGD:6480464 |
CTD |
| G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
|
multiple interactions |
EXP |
4 |
118,734,786 |
118,751,606 |
RGD:6480464 |
CTD |
| G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
4 |
118,734,786 |
118,751,606 |
RGD:6480464 |
CTD |
| G |
Cyp26c1 |
cytochrome P450, family 26, subfamily C, polypeptide 1 |
|
decreases expression |
ISO |
1 |
241,954,251 |
241,961,689 |
RGD:6480464 |
CTD |
| G |
Cyp26c1 |
cytochrome P450, family 26, subfamily C, polypeptide 1 |
|
increases expression |
ISO |
1 |
241,954,251 |
241,961,689 |
RGD:6480464 |
CTD |
| G |
Cyp2c6v1 |
cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 |
|
decreases expression |
ISO |
1 |
243,859,015 |
243,896,003 |
RGD:6480464 |
CTD |
| G |
Cyp2c79 |
cytochrome P450, family 2, subfamily c, polypeptide 79 |
|
affects metabolic processing |
ISO |
1 |
244,400,004 |
244,493,624 |
RGD:6480464 |
CTD |
| G |
Cyp2c79 |
cytochrome P450, family 2, subfamily c, polypeptide 79 |
|
increases metabolic processing |
ISO |
1 |
244,400,004 |
244,493,624 |
RGD:6480464 |
CTD |
| G |
Cyp2c80 |
cytochrome P450, family 2, subfamily c, polypeptide 80 |
|
decreases expression |
ISO |
1 |
244,517,262 |
244,536,426 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
|
decreases expression |
ISO |
5 |
116,702,370 |
116,729,722 |
RGD:6480464 |
CTD |
| G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
|
decreases expression |
ISO |
5 |
116,702,370 |
116,729,722 |
RGD:6480464 |
CTD |
| G |
Cyp2s1 |
cytochrome P450, family 2, subfamily s, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
81,008,464 |
81,023,486 |
RGD:6480464 |
CTD |
| G |
Cyp2s1 |
cytochrome P450, family 2, subfamily s, polypeptide 1 |
|
affects metabolic processing |
ISO |
1 |
81,008,464 |
81,023,486 |
RGD:6480464 |
CTD |
| G |
Cyp2s1 |
cytochrome P450, family 2, subfamily s, polypeptide 1 |
|
increases expression |
ISO |
1 |
81,008,464 |
81,023,486 |
RGD:6480464 |
CTD |
| G |
Cyp2s1 |
cytochrome P450, family 2, subfamily s, polypeptide 1 |
|
affects expression |
ISO |
1 |
81,008,464 |
81,023,486 |
RGD:6480464 |
CTD |
| G |
Cyp2u1 |
cytochrome P450, family 2, subfamily u, polypeptide 1 |
|
increases expression |
ISO |
2 |
228,771,187 |
228,788,636 |
RGD:6480464 |
CTD |
| G |
Cyp2w1 |
cytochrome P450, family 2, subfamily w, polypeptide 1 |
|
decreases expression |
ISO |
12 |
15,792,480 |
15,797,202 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases activity |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
decreases expression |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
5 |
135,901,653 |
135,915,754 |
RGD:6480464 |
CTD |
| G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
5 |
135,901,653 |
135,915,754 |
RGD:6480464 |
CTD |
| G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
5 |
135,901,653 |
135,915,754 |
RGD:6480464 |
CTD |
| G |
Cyp4b1 |
cytochrome P450, family 4, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
5 |
135,917,327 |
135,934,636 |
RGD:6480464 |
CTD |
| G |
Cyp4b1 |
cytochrome P450, family 4, subfamily b, polypeptide 1 |
|
decreases expression |
ISO |
5 |
135,917,327 |
135,934,636 |
RGD:6480464 |
CTD |
| G |
Cyp4f18 |
cytochrome P450, family 4, subfamily f, polypeptide 18 |
|
increases expression |
ISO |
16 |
18,183,761 |
18,225,158 |
RGD:6480464 |
CTD |
| G |
Cytl1 |
cytokine like 1 |
|
decreases expression |
ISO |
14 |
78,349,878 |
78,354,888 |
RGD:6480464 |
CTD |
| G |
Dag1 |
dystroglycan 1 (dystrophin-associated glycoprotein 1) |
|
decreases expression |
ISO |
8 |
113,470,871 |
113,483,433 |
RGD:6480464 |
CTD |
| G |
Dag1 |
dystroglycan 1 (dystrophin-associated glycoprotein 1) |
|
increases expression |
ISO |
8 |
113,470,871 |
113,483,433 |
RGD:6480464 |
CTD |
| G |
Dap |
death-associated protein |
|
increases expression |
ISO |
2 |
83,281,937 |
83,335,284 |
RGD:6480464 |
CTD |
| G |
Dapk1 |
death associated protein kinase 1 |
|
increases expression |
ISO |
17 |
9,617,607 |
9,779,457 |
RGD:6480464 |
CTD |
| G |
Dapk1 |
death associated protein kinase 1 |
|
affects expression |
ISO |
17 |
9,617,607 |
9,779,457 |
RGD:6480464 |
CTD |
| G |
Daxx |
death-domain associated protein |
|
multiple interactions |
ISO |
20 |
5,121,854 |
5,127,601 |
RGD:6480464 |
CTD |
| G |
Dazl |
deleted in azoospermia-like |
|
increases expression |
ISO |
9 |
5,899,104 |
5,915,835 |
RGD:6480464 |
CTD |
| G |
Dck |
deoxycytidine kinase |
|
decreases expression |
ISO |
14 |
20,886,700 |
20,904,305 |
RGD:6480464 |
CTD |
| G |
Dcx |
doublecortin |
|
increases expression |
ISO |
X |
34,596,262 |
34,672,383 |
RGD:6480464 |
CTD |
| G |
Ddah2 |
dimethylarginine dimethylaminohydrolase 2 |
|
multiple interactions |
EXP |
20 |
3,829,767 |
3,836,141 |
RGD:6480464 |
CTD |
| G |
Ddah2 |
dimethylarginine dimethylaminohydrolase 2 |
|
decreases expression |
ISO |
20 |
3,829,767 |
3,836,141 |
RGD:6480464 |
CTD |
| G |
Ddc |
dopa decarboxylase (aromatic L-amino acid decarboxylase) |
|
increases expression |
ISO |
14 |
92,698,636 |
92,788,635 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
multiple interactions |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit4 |
DNA-damage-inducible transcript 4 |
|
increases expression |
ISO |
20 |
27,252,273 |
27,254,371 |
RGD:6480464 |
CTD |
| G |
Ddx10 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 10 |
|
decreases expression |
ISO |
8 |
56,557,483 |
56,706,523 |
RGD:6480464 |
CTD |
| G |
Ddx10 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 10 |
|
multiple interactions |
ISO |
8 |
56,557,483 |
56,706,523 |
RGD:6480464 |
CTD |
| G |
Ddx18 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 18 |
|
multiple interactions |
ISO |
13 |
33,587,928 |
33,601,436 |
RGD:6480464 |
CTD |
| G |
Ddx18 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 18 |
|
decreases expression |
ISO |
13 |
33,587,928 |
33,601,436 |
RGD:6480464 |
CTD |
| G |
Ddx21 |
DEAD (Asp-Glu-Ala-Asp) box helicase 21 |
|
decreases expression |
ISO |
20 |
29,838,671 |
29,860,514 |
RGD:6480464 |
CTD |
| G |
Ddx21 |
DEAD (Asp-Glu-Ala-Asp) box helicase 21 |
|
decreases expression |
ISO |
20 |
29,838,671 |
29,860,514 |
RGD:6480464 |
CTD |
| G |
Ddx39a |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 39A |
|
decreases expression |
ISO |
19 |
26,109,094 |
26,117,042 |
RGD:6480464 |
CTD |
| G |
Ddx6 |
DEAD (Asp-Glu-Ala-Asp) box helicase 6 |
|
decreases expression |
ISO |
8 |
47,573,536 |
47,605,957 |
RGD:6480464 |
CTD |
| G |
Degs1 |
delta(4)-desaturase, sphingolipid 1 |
|
decreases expression |
ISO |
13 |
98,242,981 |
98,249,638 |
RGD:6480464 |
CTD |
| G |
Dok4 |
docking protein 4 |
|
increases expression |
ISO |
19 |
10,585,647 |
10,596,322 |
RGD:6480464 |
CTD |
| G |
Dpysl2 |
dihydropyrimidinase-like 2 |
|
multiple interactions |
ISO |
15 |
46,346,413 |
46,413,786 |
RGD:6480464 |
CTD |
| G |
Dpysl2 |
dihydropyrimidinase-like 2 |
|
decreases expression |
ISO |
15 |
46,346,413 |
46,413,786 |
RGD:6480464 |
CTD |
| G |
Drap1 |
Dr1 associated protein 1 (negative cofactor 2 alpha) |
|
increases expression |
ISO |
1 |
208,067,906 |
208,070,556 |
RGD:6480464 |
CTD |
| G |
Dsc1 |
desmocollin 1 |
|
decreases expression |
ISO |
18 |
11,953,172 |
11,979,048 |
RGD:6480464 |
CTD |
| G |
Dsc2 |
desmocollin 2 |
|
increases expression |
ISO |
18 |
11,902,185 |
11,933,989 |
RGD:6480464 |
CTD |
| G |
Dsg2 |
desmoglein 2 |
|
increases expression |
ISO |
18 |
12,306,321 |
12,366,719 |
RGD:6480464 |
CTD |
| G |
Dsp |
desmoplakin |
|
increases expression |
ISO |
17 |
32,848,313 |
32,896,044 |
RGD:6480464 |
CTD |
| G |
Dstn |
destrin |
|
decreases expression |
ISO |
3 |
132,358,484 |
132,385,198 |
RGD:6480464 |
CTD |
| G |
Duox1 |
dual oxidase 1 |
|
increases expression |
ISO |
3 |
109,095,250 |
109,128,415 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
increases expression |
ISO |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
increases expression |
EXP |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Dusp10 |
dual specificity phosphatase 10 |
|
increases expression |
ISO |
13 |
100,022,421 |
100,059,539 |
RGD:6480464 |
CTD |
| G |
Dusp11 |
dual specificity phosphatase 11 (RNA/RNP complex 1-interacting) |
|
decreases expression |
ISO |
4 |
120,094,173 |
120,108,207 |
RGD:6480464 |
CTD |
| G |
Dusp6 |
dual specificity phosphatase 6 |
|
increases expression |
ISO |
7 |
36,893,264 |
36,897,494 |
RGD:6480464 |
CTD |
| G |
Dynll1 |
dynein light chain LC8-type 1 |
|
increases expression |
ISO |
12 |
42,580,542 |
42,582,915 |
RGD:6480464 |
CTD |
| G |
Dysf |
dysferlin |
|
increases expression |
ISO |
4 |
118,213,435 |
118,371,283 |
RGD:6480464 |
CTD |
| G |
E2f1 |
E2F transcription factor 1 |
|
multiple interactions |
ISO |
3 |
145,032,489 |
145,043,729 |
RGD:6480464 |
CTD |
| G |
E2f1 |
E2F transcription factor 1 |
|
decreases expression |
ISO |
3 |
145,032,489 |
145,043,729 |
RGD:6480464 |
CTD |
| G |
E2f1 |
E2F transcription factor 1 |
|
decreases expression |
ISO |
3 |
145,032,489 |
145,043,729 |
RGD:6480464 |
CTD |
| G |
E2f1 |
E2F transcription factor 1 |
|
increases expression |
ISO |
3 |
145,032,489 |
145,043,729 |
RGD:6480464 |
CTD |
| G |
Ebna1bp2 |
EBNA1 binding protein 2 |
|
decreases expression |
ISO |
5 |
139,095,875 |
139,100,441 |
RGD:6480464 |
CTD |
| G |
Eci2 |
enoyl-CoA delta isomerase 2 |
|
decreases expression |
ISO |
17 |
36,198,752 |
36,215,199 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
multiple interactions |
ISO |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
decreases expression |
ISO |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
decreases expression |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn3 |
endothelin 3 |
|
multiple interactions |
ISO |
3 |
166,491,368 |
166,514,051 |
RGD:6480464 |
CTD |
| G |
Eef1a1 |
eukaryotic translation elongation factor 1 alpha 1 |
|
multiple interactions |
ISO |
8 |
83,463,591 |
83,466,813 |
RGD:6480464 |
CTD |
| G |
Eef1a1 |
eukaryotic translation elongation factor 1 alpha 1 |
|
increases expression |
ISO |
8 |
83,463,591 |
83,466,813 |
RGD:6480464 |
CTD |
| G |
Eef1a1 |
eukaryotic translation elongation factor 1 alpha 1 |
|
increases expression |
ISO |
8 |
83,463,591 |
83,466,813 |
RGD:6480464 |
CTD |
| G |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
|
decreases expression |
ISO |
3 |
170,295,327 |
170,304,505 |
RGD:6480464 |
CTD |
| G |
Eef1g |
eukaryotic translation elongation factor 1 gamma |
|
decreases expression |
ISO |
1 |
211,640,954 |
211,651,560 |
RGD:6480464 |
CTD |
| G |
Efnb1 |
ephrin B1 |
|
increases expression |
ISO |
X |
87,163,176 |
87,175,982 |
RGD:6480464 |
CTD |
| G |
Efnb2 |
ephrin B2 |
|
increases expression |
ISO |
16 |
86,187,639 |
86,228,023 |
RGD:6480464 |
CTD |
| G |
Efnb2 |
ephrin B2 |
|
multiple interactions |
ISO |
16 |
86,187,639 |
86,228,023 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
decreases activity |
ISO |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
ISO |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
EXP |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
decreases expression |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
decreases expression |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
multiple interactions |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases expression |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases phosphorylation |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
multiple interactions |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Ehd1 |
EH-domain containing 1 |
|
increases expression |
ISO |
1 |
209,055,234 |
209,077,609 |
RGD:6480464 |
CTD |
| G |
Ehd2 |
EH-domain containing 2 |
|
increases expression |
ISO |
1 |
76,292,179 |
76,310,584 |
RGD:6480464 |
CTD |
| G |
Ehmt2 |
euchromatic histone lysine N-methyltransferase 2 |
|
multiple interactions |
ISO |
20 |
4,021,679 |
4,033,709 |
RGD:6480464 |
CTD |
| G |
Eif1a |
eukaryotic translation initiation factor 1A |
|
decreases expression |
ISO |
18 |
40,808,057 |
40,819,421 |
RGD:6480464 |
CTD |
| G |
Eif1b |
eukaryotic translation initiation factor 1B |
|
increases expression |
ISO |
8 |
125,499,378 |
125,501,992 |
RGD:6480464 |
CTD |
| G |
Eif2a |
eukaryotic translation initiation factor 2A |
|
decreases expression |
ISO |
2 |
147,870,265 |
147,903,411 |
RGD:6480464 |
CTD |
| G |
Eif2s1 |
eukaryotic translation initiation factor 2, subunit 1 alpha |
|
decreases expression |
ISO |
6 |
101,495,444 |
101,520,113 |
RGD:6480464 |
CTD |
| G |
Eif2s3 |
eukaryotic translation initiation factor 2, subunit 3 gamma |
|
increases expression |
ISO |
X |
81,542,853 |
81,566,259 |
RGD:6480464 |
CTD |
| G |
Eif3b |
eukaryotic translation initiation factor 3, subunit B |
|
decreases expression |
ISO |
12 |
14,666,974 |
14,692,130 |
RGD:6480464 |
CTD |
| G |
Eif3b |
eukaryotic translation initiation factor 3, subunit B |
|
multiple interactions |
ISO |
12 |
14,666,974 |
14,692,130 |
RGD:6480464 |
CTD |
| G |
Eif3c |
eukaryotic translation initiation factor 3, subunit C |
|
multiple interactions |
ISO |
1 |
185,691,630 |
185,709,514 |
RGD:6480464 |
CTD |
| G |
Eif3c |
eukaryotic translation initiation factor 3, subunit C |
|
decreases expression |
ISO |
1 |
185,691,630 |
185,709,514 |
RGD:6480464 |
CTD |
| G |
Eif4a2 |
eukaryotic translation initiation factor 4A2 |
|
decreases expression |
ISO |
11 |
79,950,592 |
79,957,185 |
RGD:6480464 |
CTD |
| G |
Eif4e |
eukaryotic translation initiation factor 4E |
|
multiple interactions |
ISO |
2 |
236,072,748 |
236,104,714 |
RGD:6480464 |
CTD |
| G |
Eif4e |
eukaryotic translation initiation factor 4E |
|
decreases expression |
ISO |
2 |
236,072,748 |
236,104,714 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
multiple interactions |
ISO |
16 |
69,110,522 |
69,123,895 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
decreases expression |
ISO |
16 |
69,110,522 |
69,123,895 |
RGD:6480464 |
CTD |
| G |
Eif4ebp2 |
eukaryotic translation initiation factor 4E binding protein 2 |
|
decreases expression |
ISO |
20 |
29,562,634 |
29,579,209 |
RGD:6480464 |
CTD |
| G |
Eif4g2 |
eukaryotic translation initiation factor 4, gamma 2 |
|
multiple interactions |
ISO |
1 |
168,829,099 |
168,841,605 |
RGD:6480464 |
CTD |
| G |
Eif4g2 |
eukaryotic translation initiation factor 4, gamma 2 |
|
multiple interactions |
ISO |
1 |
168,829,099 |
168,841,605 |
RGD:6480464 |
CTD |
| G |
Eif4g2 |
eukaryotic translation initiation factor 4, gamma 2 |
|
increases expression |
ISO |
1 |
168,829,099 |
168,841,605 |
RGD:6480464 |
CTD |
| G |
Elf1 |
E74-like factor 1 |
|
affects expression |
ISO |
15 |
60,793,794 |
60,835,189 |
RGD:6480464 |
CTD |
| G |
Elf1 |
E74-like factor 1 |
|
increases expression |
ISO |
15 |
60,793,794 |
60,835,189 |
RGD:6480464 |
CTD |
| G |
Elf2 |
E74-like factor 2 |
|
affects expression |
ISO |
2 |
140,144,023 |
140,221,693 |
RGD:6480464 |
CTD |
| G |
Elf3 |
E74-like factor 3 |
|
increases expression |
ISO |
13 |
48,258,893 |
48,263,713 |
RGD:6480464 |
CTD |
| G |
Elf3 |
E74-like factor 3 |
|
increases expression |
ISO |
13 |
48,258,893 |
48,263,713 |
RGD:6480464 |
CTD |
| G |
Elf4 |
E74-like factor 4 (ets domain transcription factor) |
|
increases expression |
ISO |
X |
134,808,886 |
134,818,835 |
RGD:6480464 |
CTD |
| G |
Eln |
elastin |
|
increases expression |
EXP |
12 |
23,033,657 |
23,077,043 |
RGD:6480464 |
CTD |
| G |
Emp1 |
epithelial membrane protein 1 |
|
increases expression |
ISO |
4 |
172,315,122 |
172,335,536 |
RGD:6480464 |
CTD |
| G |
Emp1 |
epithelial membrane protein 1 |
|
increases expression |
ISO |
4 |
172,315,122 |
172,335,536 |
RGD:6480464 |
CTD |
| G |
Emp3 |
epithelial membrane protein 3 |
|
increases expression |
ISO |
1 |
96,389,783 |
96,392,960 |
RGD:6480464 |
CTD |
| G |
En1 |
engrailed homeobox 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Enc1 |
ectodermal-neural cortex 1 |
|
decreases expression |
ISO |
2 |
27,720,805 |
27,733,168 |
RGD:6480464 |
CTD |
| G |
Fam171a1 |
family with sequence similarity 171, member A1 |
|
increases expression |
ISO |
17 |
86,143,621 |
86,266,740 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
multiple interactions |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
multiple interactions |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
decreases expression |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
decreases expression |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
increases expression |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
increases expression |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
multiple interactions |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
decreases expression |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fastk |
Fas-activated serine/threonine kinase |
|
decreases expression |
ISO |
4 |
6,096,675 |
6,100,690 |
RGD:6480464 |
CTD |
| G |
Fbln1 |
fibulin 1 |
|
increases expression |
ISO |
7 |
123,208,154 |
123,287,289 |
RGD:6480464 |
CTD |
| G |
Fbp1 |
fructose-1,6-bisphosphatase 1 |
|
increases expression |
ISO |
17 |
7,795,717 |
7,818,041 |
RGD:6480464 |
CTD |
| G |
Fbp2 |
fructose-1,6-bisphosphatase 2 |
|
increases expression |
ISO |
17 |
7,824,298 |
7,841,661 |
RGD:6480464 |
CTD |
| G |
Fcer1g |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
increases expression |
ISO |
13 |
87,119,464 |
87,123,902 |
RGD:6480464 |
CTD |
| G |
Fcer2 |
Fc fragment of IgE, low affinity II, receptor for (CD23) |
|
increases expression |
ISO |
12 |
2,444,054 |
2,469,678 |
RGD:6480464 |
CTD |
| G |
Fcgr3a |
Fc fragment of IgG, low affinity IIIa, receptor |
|
increases expression |
ISO |
13 |
86,867,641 |
86,877,665 |
RGD:6480464 |
CTD |
| G |
Fcgrt |
Fc fragment of IgG, receptor, transporter, alpha |
|
increases expression |
ISO |
1 |
95,566,717 |
95,575,645 |
RGD:6480464 |
CTD |
| G |
Fen1 |
flap structure-specific endonuclease 1 |
|
decreases expression |
ISO |
1 |
212,688,118 |
212,692,486 |
RGD:6480464 |
CTD |
| G |
Fgf1 |
fibroblast growth factor 1 (acidic) |
|
decreases expression |
ISO |
18 |
31,785,480 |
31,806,452 |
RGD:6480464 |
CTD |
| G |
Fgf10 |
fibroblast growth factor 10 |
|
affects expression |
ISO |
2 |
50,866,799 |
50,940,319 |
RGD:6480464 |
CTD |
| G |
Fgf10 |
fibroblast growth factor 10 |
|
increases expression |
ISO |
2 |
50,866,799 |
50,940,319 |
RGD:6480464 |
CTD |
| G |
Fgf10 |
fibroblast growth factor 10 |
|
increases expression |
EXP |
2 |
50,866,799 |
50,940,319 |
RGD:6480464 |
CTD |
| G |
Fgf12 |
fibroblast growth factor 12 |
|
decreases expression |
ISO |
11 |
74,208,696 |
74,481,037 |
RGD:6480464 |
CTD |
| G |
Fgf17 |
fibroblast growth factor 17 |
|
decreases expression |
ISO |
15 |
51,038,529 |
51,044,118 |
RGD:6480464 |
CTD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
multiple interactions |
ISO |
2 |
123,893,314 |
123,947,136 |
RGD:6480464 |
CTD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
decreases response to substance |
ISO |
2 |
123,893,314 |
123,947,136 |
RGD:6480464 |
CTD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
multiple interactions |
EXP |
2 |
123,893,314 |
123,947,136 |
RGD:6480464 |
CTD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
decreases response to substance |
EXP |
2 |
123,893,314 |
123,947,136 |
RGD:6480464 |
CTD |
| G |
Fgf3 |
fibroblast growth factor 3 |
|
affects localization |
ISO |
1 |
205,269,480 |
205,273,404 |
RGD:6480464 |
CTD |
| G |
Fgf3 |
fibroblast growth factor 3 |
|
affects expression |
ISO |
1 |
205,269,480 |
205,273,404 |
RGD:6480464 |
CTD |
| G |
Fgf4 |
fibroblast growth factor 4 |
|
multiple interactions |
ISO |
1 |
205,292,272 |
205,293,705 |
RGD:6480464 |
CTD |
| G |
Fgf8 |
fibroblast growth factor 8 |
|
multiple interactions |
ISO |
1 |
250,951,023 |
250,956,730 |
RGD:6480464 |
CTD |
| G |
Fgf8 |
fibroblast growth factor 8 |
|
multiple interactions |
ISO |
1 |
250,951,023 |
250,956,730 |
RGD:6480464 |
CTD |
| G |
Fgf8 |
fibroblast growth factor 8 |
|
decreases expression |
ISO |
1 |
250,951,023 |
250,956,730 |
RGD:6480464 |
CTD |
| G |
Fgf8 |
fibroblast growth factor 8 |
|
decreases expression |
ISO |
1 |
250,951,023 |
250,956,730 |
RGD:6480464 |
CTD |
| G |
Fgf9 |
fibroblast growth factor 9 |
|
increases expression |
ISO |
15 |
37,115,068 |
37,155,652 |
RGD:6480464 |
CTD |
| G |
Fgfbp1 |
fibroblast growth factor binding protein 1 |
|
decreases expression |
ISO |
14 |
72,242,271 |
72,243,353 |
RGD:6480464 |
CTD |
| G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
increases expression |
ISO |
16 |
70,869,974 |
70,910,045 |
RGD:6480464 |
CTD |
| G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
increases expression |
EXP |
16 |
70,869,974 |
70,910,045 |
RGD:6480464 |
CTD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
decreases expression |
ISO |
1 |
189,482,975 |
189,589,279 |
RGD:6480464 |
CTD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
decreases expression |
EXP |
1 |
189,482,975 |
189,589,279 |
RGD:6480464 |
CTD |
| G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
decreases expression |
ISO |
14 |
82,683,191 |
82,697,229 |
RGD:6480464 |
CTD |
| G |
Fgfr4 |
fibroblast growth factor receptor 4 |
|
decreases expression |
ISO |
17 |
15,512,144 |
15,527,348 |
RGD:6480464 |
CTD |
| G |
Fgr |
Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog |
|
increases expression |
ISO |
5 |
152,119,455 |
152,147,057 |
RGD:6480464 |
CTD |
| G |
Fhl5 |
four and a half LIM domains 5 |
|
increases expression |
ISO |
5 |
40,253,199 |
40,301,542 |
RGD:6480464 |
CTD |
| G |
Fkbp8 |
FK506 binding protein 8 |
|
decreases expression |
ISO |
16 |
19,401,883 |
19,407,192 |
RGD:6480464 |
CTD |
| G |
Flg |
filaggrin |
|
increases expression |
ISO |
2 |
186,307,359 |
186,311,549 |
RGD:6480464 |
CTD |
| G |
Flg |
filaggrin |
|
decreases expression |
ISO |
2 |
186,307,359 |
186,311,549 |
RGD:6480464 |
CTD |
| G |
Fli1 |
Friend leukemia virus integration 1 |
|
increases expression |
ISO |
8 |
32,187,952 |
32,309,782 |
RGD:6480464 |
CTD |
| G |
Flnb |
filamin B, beta |
|
increases expression |
ISO |
15 |
18,949,027 |
19,082,504 |
RGD:6480464 |
CTD |
| G |
Flt3 |
fms-related tyrosine kinase 3 |
|
multiple interactions |
ISO |
12 |
8,193,629 |
8,268,682 |
RGD:6480464 |
CTD |
| G |
Flt3 |
fms-related tyrosine kinase 3 |
|
increases response to substance |
ISO |
12 |
8,193,629 |
8,268,682 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
multiple interactions |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
increases expression |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
multiple interactions |
EXP |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fndc7 |
fibronectin type III domain containing 7 |
|
decreases expression |
ISO |
2 |
204,456,114 |
204,493,579 |
RGD:6480464 |
CTD |
| G |
Folr1 |
folate receptor 1 (adult) |
|
increases expression |
ISO |
1 |
159,315,191 |
159,324,141 |
RGD:6480464 |
CTD |
| G |
Folr2 |
folate receptor 2 (fetal) |
|
multiple interactions |
ISO |
1 |
159,295,773 |
159,314,107 |
RGD:6480464 |
CTD |
| G |
Folr2 |
folate receptor 2 (fetal) |
|
increases expression |
ISO |
1 |
159,295,773 |
159,314,107 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
decreases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
decreases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Foxa1 |
forkhead box A1 |
|
increases expression |
ISO |
6 |
77,976,384 |
78,009,176 |
RGD:6480464 |
CTD |
| G |
Foxa1 |
forkhead box A1 |
|
increases expression |
ISO |
6 |
77,976,384 |
78,009,176 |
RGD:6480464 |
CTD |
| G |
Foxa2 |
forkhead box A2 |
|
decreases expression |
ISO |
3 |
136,739,009 |
136,743,204 |
RGD:6480464 |
CTD |
| G |
Foxj1 |
forkhead box J1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Foxq1 |
forkhead box Q1 |
|
increases expression |
ISO |
17 |
39,332,906 |
39,334,655 |
RGD:6480464 |
CTD |
| G |
Fst |
follistatin |
|
decreases expression |
ISO |
2 |
46,542,246 |
46,550,678 |
RGD:6480464 |
CTD |
| G |
Ftl |
ferritin, light polypeptide |
|
increases expression |
ISO |
1 |
95,929,248 |
95,931,092 |
RGD:6480464 |
CTD |
| G |
Gdnf |
glial cell derived neurotrophic factor |
|
multiple interactions |
ISO |
2 |
57,399,312 |
57,424,030 |
RGD:6480464 |
CTD |
| G |
Gdnf |
glial cell derived neurotrophic factor |
|
decreases expression |
ISO |
2 |
57,399,312 |
57,424,030 |
RGD:6480464 |
CTD |
| G |
Gdnf |
glial cell derived neurotrophic factor |
|
increases secretion |
ISO |
2 |
57,399,312 |
57,424,030 |
RGD:6480464 |
CTD |
| G |
Gdnf |
glial cell derived neurotrophic factor |
|
multiple interactions |
ISO |
2 |
57,399,312 |
57,424,030 |
RGD:6480464 |
CTD |
| G |
Gdpd5 |
glycerophosphodiester phosphodiesterase domain containing 5 |
|
increases expression |
ISO |
1 |
156,703,241 |
156,794,530 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
multiple interactions |
ISO |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
increases expression |
ISO |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
decreases expression |
EXP |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfi1 |
growth factor independent 1 transcription repressor |
|
decreases expression |
ISO |
14 |
2,597,303 |
2,606,681 |
RGD:6480464 |
CTD |
| G |
Gfra1 |
GDNF family receptor alpha 1 |
|
multiple interactions |
ISO |
1 |
264,614,329 |
264,875,486 |
RGD:6480464 |
CTD |
| G |
Gfra1 |
GDNF family receptor alpha 1 |
|
multiple interactions |
ISO |
1 |
264,614,329 |
264,875,486 |
RGD:6480464 |
CTD |
| G |
Gfra1 |
GDNF family receptor alpha 1 |
|
increases expression |
ISO |
1 |
264,614,329 |
264,875,486 |
RGD:6480464 |
CTD |
| G |
Gfra1 |
GDNF family receptor alpha 1 |
|
decreases expression |
EXP |
1 |
264,614,329 |
264,875,486 |
RGD:6480464 |
CTD |
| G |
Gfra2 |
GDNF family receptor alpha 2 |
|
affects expression |
ISO |
15 |
51,279,770 |
51,371,053 |
RGD:6480464 |
CTD |
| G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gh1 |
growth hormone 1 |
|
affects expression |
EXP |
10 |
95,692,240 |
95,694,117 |
RGD:6480464 |
CTD |
| G |
Gh1 |
growth hormone 1 |
|
increases expression |
EXP |
10 |
95,692,240 |
95,694,117 |
RGD:6480464 |
CTD |
| G |
Ghrh |
growth hormone releasing hormone |
|
multiple interactions |
EXP |
3 |
148,027,235 |
148,046,352 |
RGD:6480464 |
CTD |
| G |
Gins1 |
GINS complex subunit 1 (Psf1 homolog) |
|
decreases expression |
ISO |
3 |
141,535,210 |
141,557,391 |
RGD:6480464 |
CTD |
| G |
Gins2 |
GINS complex subunit 2 (Psf2 homolog) |
|
decreases expression |
ISO |
19 |
50,915,108 |
50,927,668 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
increases expression |
ISO |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gjb1 |
gap junction protein, beta 1 |
|
increases expression |
ISO |
X |
89,448,873 |
89,456,812 |
RGD:6480464 |
CTD |
| G |
Gjb2 |
gap junction protein, beta 2 |
|
increases expression |
ISO |
15 |
36,153,526 |
36,159,490 |
RGD:6480464 |
CTD |
| G |
Gjb5 |
gap junction protein, beta 5 |
|
decreases expression |
ISO |
5 |
146,802,849 |
146,803,664 |
RGD:6480464 |
CTD |
| G |
Gli1 |
GLI family zinc finger 1 |
|
multiple interactions |
ISO |
7 |
67,288,291 |
67,297,461 |
RGD:6480464 |
CTD |
| G |
Glrx3 |
glutaredoxin 3 |
|
decreases expression |
ISO |
1 |
197,176,020 |
197,206,249 |
RGD:6480464 |
CTD |
| G |
Glud1 |
glutamate dehydrogenase 1 |
|
multiple interactions |
ISO |
16 |
9,965,718 |
9,999,254 |
RGD:6480464 |
CTD |
| G |
Glud1 |
glutamate dehydrogenase 1 |
|
decreases expression |
ISO |
16 |
9,965,718 |
9,999,254 |
RGD:6480464 |
CTD |
| G |
Glul |
glutamate-ammonia ligase |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gna13 |
guanine nucleotide binding protein (G protein), alpha 13 |
|
multiple interactions |
ISO |
10 |
98,933,205 |
98,965,819 |
RGD:6480464 |
CTD |
| G |
Gna13 |
guanine nucleotide binding protein (G protein), alpha 13 |
|
increases expression |
ISO |
10 |
98,933,205 |
98,965,819 |
RGD:6480464 |
CTD |
| G |
Gnat1 |
guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 1 |
|
increases expression |
ISO |
8 |
112,925,418 |
112,930,154 |
RGD:6480464 |
CTD |
| G |
Gnl3 |
guanine nucleotide binding protein-like 3 (nucleolar) |
|
decreases expression |
ISO |
16 |
6,444,437 |
6,450,375 |
RGD:6480464 |
CTD |
| G |
Gnpnat1 |
glucosamine-phosphate N-acetyltransferase 1 |
|
decreases expression |
ISO |
15 |
21,272,165 |
21,284,459 |
RGD:6480464 |
CTD |
| G |
Gns |
glucosamine (N-acetyl)-6-sulfatase |
|
increases expression |
ISO |
7 |
60,672,492 |
60,702,306 |
RGD:6480464 |
CTD |
| G |
Gpd1 |
glycerol-3-phosphate dehydrogenase 1 (soluble) |
|
decreases expression |
ISO |
7 |
138,458,875 |
138,466,266 |
RGD:6480464 |
CTD |
| G |
Gpnmb |
glycoprotein (transmembrane) nmb |
|
increases expression |
ISO |
4 |
77,161,352 |
77,182,624 |
RGD:6480464 |
CTD |
| G |
Gpr137b |
G protein-coupled receptor 137B |
|
increases expression |
ISO |
17 |
66,993,915 |
67,004,339 |
RGD:6480464 |
CTD |
| G |
Gprc5a |
G protein-coupled receptor, family C, group 5, member A |
|
increases expression |
ISO |
4 |
171,987,364 |
172,006,276 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
multiple interactions |
ISO |
6 |
99,372,418 |
99,376,230 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
increases activity |
ISO |
6 |
99,372,418 |
99,376,230 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
increases expression |
ISO |
6 |
99,372,418 |
99,376,230 |
RGD:6480464 |
CTD |
| G |
Gpx4 |
glutathione peroxidase 4 |
|
decreases activity |
ISO |
7 |
11,162,521 |
11,165,318 |
RGD:6480464 |
CTD |
| G |
Grb10 |
growth factor receptor bound protein 10 |
|
decreases expression |
ISO |
14 |
92,814,797 |
92,911,442 |
RGD:6480464 |
CTD |
| G |
Grb10 |
growth factor receptor bound protein 10 |
|
multiple interactions |
ISO |
14 |
92,814,797 |
92,911,442 |
RGD:6480464 |
CTD |
| G |
Grb7 |
growth factor receptor bound protein 7 |
|
decreases expression |
ISO |
10 |
87,252,571 |
87,261,619 |
RGD:6480464 |
CTD |
| G |
Gria2 |
glutamate receptor, ionotropic, AMPA 2 |
|
decreases expression |
ISO |
2 |
172,265,155 |
172,385,285 |
RGD:6480464 |
CTD |
| G |
Grid1 |
glutamate receptor, ionotropic, delta 1 |
|
decreases expression |
ISO |
16 |
10,473,353 |
11,202,161 |
RGD:6480464 |
CTD |
| G |
Grik5 |
glutamate receptor, ionotropic, kainate 5 |
|
decreases expression |
ISO |
1 |
80,313,801 |
80,384,390 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
increases expression |
ISO |
4 |
172,721,895 |
173,183,187 |
RGD:6480464 |
CTD |
| G |
Grn |
granulin |
|
affects expression |
ISO |
10 |
91,536,135 |
91,542,239 |
RGD:6480464 |
CTD |
| G |
Grn |
granulin |
|
increases expression |
ISO |
10 |
91,536,135 |
91,542,239 |
RGD:6480464 |
CTD |
| G |
Gse1 |
Gse1 coiled-coil protein |
|
increases expression |
ISO |
19 |
50,874,475 |
50,916,263 |
RGD:6480464 |
CTD |
| G |
Gsk3a |
glycogen synthase kinase 3 alpha |
|
decreases phosphorylation |
ISO |
1 |
80,505,517 |
80,514,139 |
RGD:6480464 |
CTD |
| G |
Gsk3a |
glycogen synthase kinase 3 alpha |
|
increases phosphorylation |
ISO |
1 |
80,505,517 |
80,514,139 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases phosphorylation |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
increases phosphorylation |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsn |
gelsolin |
|
increases expression |
ISO |
3 |
14,360,245 |
14,386,313 |
RGD:6480464 |
CTD |
| G |
Gsn |
gelsolin |
|
increases expression |
ISO |
3 |
14,360,245 |
14,386,313 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
increases expression |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
decreases expression |
ISO |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase mu 2 |
|
decreases expression |
ISO |
2 |
203,549,022 |
203,553,380 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
ISO |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
decreases expression |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
increases expression |
ISO |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gtf2a1 |
general transcription factor IIA, 1 |
|
decreases expression |
ISO |
6 |
115,180,871 |
115,210,825 |
RGD:6480464 |
CTD |
| G |
Gtf2a1l |
general transcription factor IIA, 1-like |
|
decreases expression |
ISO |
6 |
12,527,076 |
12,583,946 |
RGD:6480464 |
CTD |
| G |
Gtf2a2 |
general transcription factor IIA, 2 |
|
decreases expression |
ISO |
8 |
74,447,866 |
74,456,735 |
RGD:6480464 |
CTD |
| G |
Gtf2h3 |
general transcription factor IIH, polypeptide 3 |
|
decreases expression |
ISO |
12 |
33,121,881 |
33,138,233 |
RGD:6480464 |
CTD |
| G |
Gtf3a |
general transcription factor III A |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gtse1 |
G-2 and S-phase expressed 1 |
|
decreases expression |
ISO |
7 |
123,862,066 |
123,878,554 |
RGD:6480464 |
CTD |
| G |
H19 |
H19, imprinted maternally expressed transcript (non-protein coding) |
|
increases expression |
ISO |
1 |
202,822,925 |
202,825,601 |
RGD:6480464 |
CTD |
| G |
H1f0 |
H1 histone family, member 0 |
|
increases expression |
ISO |
7 |
117,001,334 |
117,003,194 |
RGD:6480464 |
CTD |
| G |
H1f0 |
H1 histone family, member 0 |
|
affects expression |
ISO |
7 |
117,001,334 |
117,003,194 |
RGD:6480464 |
CTD |
| G |
H1foo |
H1 histone family, member O, oocyte-specific |
|
increases expression |
ISO |
4 |
152,070,310 |
152,075,730 |
RGD:6480464 |
CTD |
| G |
H1fx |
H1 histone family, member X |
|
increases expression |
ISO |
4 |
122,179,764 |
122,180,823 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
decreases expression |
ISO |
8 |
47,312,609 |
47,313,938 |
RGD:6480464 |
CTD |
| G |
Hal |
histidine ammonia lyase |
|
increases expression |
ISO |
7 |
30,520,913 |
30,551,145 |
RGD:6480464 |
CTD |
| G |
Hmgb2 |
high mobility group box 2 |
|
decreases expression |
ISO |
16 |
36,131,304 |
36,133,878 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
decreases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox2 |
heme oxygenase (decycling) 2 |
|
multiple interactions |
ISO |
10 |
10,914,157 |
10,929,448 |
RGD:6480464 |
CTD |
| G |
Hnf1b |
HNF1 homeobox B |
|
increases expression |
ISO |
10 |
72,081,091 |
72,187,014 |
RGD:6480464 |
CTD |
| G |
Hnrnpab |
heterogeneous nuclear ribonucleoprotein A/B |
|
multiple interactions |
ISO |
10 |
37,117,285 |
37,123,177 |
RGD:6480464 |
CTD |
| G |
Hnrnpab |
heterogeneous nuclear ribonucleoprotein A/B |
|
decreases expression |
ISO |
10 |
37,117,285 |
37,123,177 |
RGD:6480464 |
CTD |
| G |
Hnrnph2 |
heterogeneous nuclear ribonucleoprotein H2 (H') |
|
multiple interactions |
ISO |
X |
122,056,647 |
122,061,844 |
RGD:6480464 |
CTD |
| G |
Hnrnph2 |
heterogeneous nuclear ribonucleoprotein H2 (H') |
|
increases expression |
ISO |
X |
122,056,647 |
122,061,844 |
RGD:6480464 |
CTD |
| G |
Hnrnph3 |
heterogeneous nuclear ribonucleoprotein H3 (2H9) |
|
multiple interactions |
ISO |
20 |
25,353,281 |
25,358,138 |
RGD:6480464 |
CTD |
| G |
Hnrnph3 |
heterogeneous nuclear ribonucleoprotein H3 (2H9) |
|
decreases expression |
ISO |
20 |
25,353,281 |
25,358,138 |
RGD:6480464 |
CTD |
| G |
Hnrpd |
heterogeneous nuclear ribonucleoprotein D |
|
increases expression |
ISO |
14 |
10,917,674 |
10,935,989 |
RGD:6480464 |
CTD |
| G |
Hopx |
HOP homeobox |
|
increases expression |
ISO |
14 |
33,369,052 |
33,377,948 |
RGD:6480464 |
CTD |
| G |
Hoxa1 |
homeo box A1 |
|
increases expression |
ISO |
4 |
80,456,728 |
80,458,388 |
RGD:6480464 |
CTD |
| G |
Hoxa1 |
homeo box A1 |
|
multiple interactions |
ISO |
4 |
80,456,728 |
80,458,388 |
RGD:6480464 |
CTD |
| G |
Hoxa1 |
homeo box A1 |
|
multiple interactions |
ISO |
4 |
80,456,728 |
80,458,388 |
RGD:6480464 |
CTD |
| G |
Hoxa1 |
homeo box A1 |
|
affects expression |
ISO |
4 |
80,456,728 |
80,458,388 |
RGD:6480464 |
CTD |
| G |
Hoxa1 |
homeo box A1 |
|
increases expression |
ISO |
4 |
80,456,728 |
80,458,388 |
RGD:6480464 |
CTD |
| G |
Hoxa1 |
homeo box A1 |
|
increases expression |
EXP |
4 |
80,456,728 |
80,458,388 |
RGD:6480464 |
CTD |
| G |
Hoxa1 |
homeo box A1 |
|
increases expression |
ISO |
4 |
80,456,728 |
80,458,388 |
RGD:6480464 |
CTD |
| G |
Hoxa11 |
homeobox A11 |
|
increases expression |
ISO |
4 |
80,542,417 |
80,546,079 |
RGD:6480464 |
CTD |
| G |
Hoxa2 |
homeo box A2 |
|
increases expression |
ISO |
4 |
80,462,651 |
80,464,927 |
RGD:6480464 |
CTD |
| G |
Hoxa4 |
homeo box A4 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hoxa4 |
homeo box A4 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hoxa5 |
homeo box A5 |
|
increases expression |
ISO |
4 |
80,501,675 |
80,504,626 |
RGD:6480464 |
CTD |
| G |
Hoxa5 |
homeo box A5 |
|
increases expression |
ISO |
4 |
80,501,675 |
80,504,626 |
RGD:6480464 |
CTD |
| G |
Hoxa6 |
homeobox A6 |
|
increases expression |
ISO |
4 |
80,506,290 |
80,508,743 |
RGD:6480464 |
CTD |
| G |
Hoxb1 |
homeo box B1 |
|
increases expression |
ISO |
10 |
85,098,903 |
85,100,308 |
RGD:6480464 |
CTD |
| G |
Hoxb13 |
homeo box B13 |
|
increases expression |
ISO |
10 |
84,925,520 |
84,927,793 |
RGD:6480464 |
CTD |
| G |
Hoxb3 |
homeo box B3 |
|
increases expression |
ISO |
10 |
85,076,528 |
85,079,216 |
RGD:6480464 |
CTD |
| G |
Hoxb4 |
homeo box B4 |
|
increases expression |
ISO |
10 |
85,050,695 |
85,053,277 |
RGD:6480464 |
CTD |
| G |
Hoxb5 |
homeo box B5 |
|
increases expression |
ISO |
10 |
85,035,516 |
85,037,724 |
RGD:6480464 |
CTD |
| G |
Hoxb5 |
homeo box B5 |
|
increases expression |
ISO |
10 |
85,035,516 |
85,037,724 |
RGD:6480464 |
CTD |
| G |
Hoxb6 |
homeo box B6 |
|
increases expression |
ISO |
10 |
85,030,558 |
85,033,604 |
RGD:6480464 |
CTD |
| G |
Hoxb7 |
homeo box B7 |
|
increases expression |
ISO |
10 |
85,017,440 |
85,020,858 |
RGD:6480464 |
CTD |
| G |
Hoxb8 |
homeo box B8 |
|
increases expression |
ISO |
10 |
85,013,711 |
85,015,462 |
RGD:6480464 |
CTD |
| G |
Hoxb8 |
homeo box B8 |
|
increases expression |
ISO |
10 |
85,013,711 |
85,015,462 |
RGD:6480464 |
CTD |
| G |
Hoxb9 |
homeo box B9 |
|
increases expression |
ISO |
10 |
85,002,254 |
85,005,760 |
RGD:6480464 |
CTD |
| G |
Hoxb9 |
homeo box B9 |
|
increases expression |
ISO |
10 |
85,002,254 |
85,005,760 |
RGD:6480464 |
CTD |
| G |
Hoxc10 |
homeo box C10 |
|
increases expression |
ISO |
7 |
141,717,910 |
141,734,613 |
RGD:6480464 |
CTD |
| G |
Hoxc4 |
homeo box C4 |
|
increases expression |
ISO |
7 |
141,796,934 |
141,799,476 |
RGD:6480464 |
CTD |
| G |
Hoxc4 |
homeo box C4 |
|
multiple interactions |
ISO |
7 |
141,796,934 |
141,799,476 |
RGD:6480464 |
CTD |
| G |
Hoxc4 |
homeo box C4 |
|
increases expression |
ISO |
7 |
141,796,934 |
141,799,476 |
RGD:6480464 |
CTD |
| G |
Hoxd1 |
homeo box D1 |
|
increases expression |
ISO |
3 |
57,377,839 |
57,379,978 |
RGD:6480464 |
CTD |
| G |
Hoxd12 |
homeo box D12 |
|
decreases expression |
ISO |
3 |
57,290,344 |
57,291,465 |
RGD:6480464 |
CTD |
| G |
Hoxd4 |
homeo box D4 |
|
increases expression |
ISO |
3 |
57,326,880 |
57,343,942 |
RGD:6480464 |
CTD |
| G |
Hoxd4 |
homeo box D4 |
|
multiple interactions |
ISO |
3 |
57,326,880 |
57,343,942 |
RGD:6480464 |
CTD |
| G |
Hras |
Harvey rat sarcoma virus oncogene |
|
decreases expression |
ISO |
1 |
201,385,705 |
201,388,987 |
RGD:6480464 |
CTD |
| G |
Hsd17b1 |
hydroxysteroid (17-beta) dehydrogenase 1 |
|
increases expression |
ISO |
10 |
90,094,249 |
90,096,451 |
RGD:6480464 |
CTD |
| G |
Hsd17b1 |
hydroxysteroid (17-beta) dehydrogenase 1 |
|
increases activity |
ISO |
10 |
90,094,249 |
90,096,451 |
RGD:6480464 |
CTD |
| G |
Hsd17b11 |
hydroxysteroid (17-beta) dehydrogenase 11 |
|
decreases expression |
ISO |
14 |
6,859,573 |
6,891,511 |
RGD:6480464 |
CTD |
| G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
|
increases expression |
ISO |
19 |
47,729,519 |
47,802,933 |
RGD:6480464 |
CTD |
| G |
Hsp90ab1 |
heat shock protein 90 alpha (cytosolic), class B member 1 |
|
decreases expression |
ISO |
9 |
11,033,496 |
11,038,868 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
multiple interactions |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa8 |
heat shock 70kDa protein 8 |
|
decreases expression |
ISO |
8 |
43,784,035 |
43,787,760 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
decreases expression |
ISO |
9 |
53,884,193 |
53,895,043 |
RGD:6480464 |
CTD |
| G |
Hspe1 |
heat shock protein 1 (chaperonin 10) |
|
decreases expression |
ISO |
9 |
53,895,333 |
53,898,421 |
RGD:6480464 |
CTD |
| G |
Htatsf1 |
HIV-1 Tat specific factor 1 |
|
increases expression |
ISO |
X |
141,697,471 |
141,711,652 |
RGD:6480464 |
CTD |
| G |
Ibsp |
integrin-binding sialoprotein |
|
multiple interactions |
ISO |
14 |
6,548,541 |
6,561,165 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
decreases expression |
EXP |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
EXP |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Id1 |
inhibitor of DNA binding 1 |
|
increases expression |
ISO |
3 |
143,086,162 |
143,087,289 |
RGD:6480464 |
CTD |
| G |
Id1 |
inhibitor of DNA binding 1 |
|
multiple interactions |
ISO |
3 |
143,086,162 |
143,087,289 |
RGD:6480464 |
CTD |
| G |
Id1 |
inhibitor of DNA binding 1 |
|
increases expression |
ISO |
3 |
143,086,162 |
143,087,289 |
RGD:6480464 |
CTD |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
affects expression |
ISO |
6 |
42,781,476 |
42,783,307 |
RGD:6480464 |
CTD |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
increases expression |
ISO |
6 |
42,781,476 |
42,783,307 |
RGD:6480464 |
CTD |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
decreases expression |
ISO |
6 |
42,781,476 |
42,783,307 |
RGD:6480464 |
CTD |
| G |
Id3 |
inhibitor of DNA binding 3 |
|
affects expression |
ISO |
5 |
154,934,138 |
154,935,707 |
RGD:6480464 |
CTD |
| G |
Id3 |
inhibitor of DNA binding 3 |
|
increases expression |
ISO |
5 |
154,934,138 |
154,935,707 |
RGD:6480464 |
CTD |
| G |
Ier2 |
immediate early response 2 |
|
decreases expression |
ISO |
19 |
25,159,276 |
25,160,800 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
multiple interactions |
ISO |
20 |
3,076,568 |
3,077,772 |
RGD:6480464 |
CTD |
| G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
increases expression |
ISO |
9 |
72,003,637 |
72,016,263 |
RGD:6480464 |
CTD |
| G |
Igfbp6 |
insulin-like growth factor binding protein 6 |
|
decreases expression |
ISO |
7 |
140,885,388 |
140,890,028 |
RGD:6480464 |
CTD |
| G |
Igfbp6 |
insulin-like growth factor binding protein 6 |
|
increases expression |
ISO |
7 |
140,885,388 |
140,890,028 |
RGD:6480464 |
CTD |
| G |
Igsf8 |
immunoglobulin superfamily, member 8 |
|
increases expression |
ISO |
13 |
88,301,142 |
88,309,250 |
RGD:6480464 |
CTD |
| G |
Ihh |
Indian hedgehog |
|
decreases expression |
ISO |
9 |
74,287,115 |
74,293,332 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
increases expression |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
increases secretion |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10ra |
interleukin 10 receptor, alpha |
|
decreases expression |
ISO |
8 |
48,211,040 |
48,224,439 |
RGD:6480464 |
CTD |
| G |
Il12a |
interleukin 12A |
|
multiple interactions |
ISO |
2 |
158,710,261 |
158,717,689 |
RGD:6480464 |
CTD |
| G |
Il12a |
interleukin 12A |
|
decreases expression |
ISO |
2 |
158,710,261 |
158,717,689 |
RGD:6480464 |
CTD |
| G |
Il12a |
interleukin 12A |
|
multiple interactions |
ISO |
2 |
158,710,261 |
158,717,689 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
multiple interactions |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
decreases expression |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
multiple interactions |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
multiple interactions |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Il13 |
interleukin 13 |
|
increases expression |
ISO |
10 |
39,093,512 |
39,096,069 |
RGD:6480464 |
CTD |
| G |
Il13ra2 |
interleukin 13 receptor, alpha 2 |
|
increases expression |
ISO |
X |
30,505,850 |
30,533,002 |
RGD:6480464 |
CTD |
| G |
Il18 |
interleukin 18 |
|
affects expression |
ISO |
8 |
53,936,584 |
53,943,228 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
multiple interactions |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
affects activity |
EXP |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
multiple interactions |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
decreases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
decreases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
decreases activity |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
multiple interactions |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
decreases expression |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
increases expression |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
increases expression |
EXP |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
multiple interactions |
EXP |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il24 |
interleukin 24 |
|
decreases expression |
ISO |
13 |
43,831,510 |
43,836,908 |
RGD:6480464 |
CTD |
| G |
Il3 |
interleukin 3 |
|
multiple interactions |
ISO |
10 |
39,684,691 |
39,687,041 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
multiple interactions |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
decreases activity |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
multiple interactions |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
increases expression |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
increases expression |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
increases secretion |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
multiple interactions |
EXP |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il5 |
interleukin 5 |
|
decreases activity |
ISO |
10 |
39,177,786 |
39,180,657 |
RGD:6480464 |
CTD |
| G |
Il5 |
interleukin 5 |
|
multiple interactions |
ISO |
10 |
39,177,786 |
39,180,657 |
RGD:6480464 |
CTD |
| G |
Il5 |
interleukin 5 |
|
increases expression |
ISO |
10 |
39,177,786 |
39,180,657 |
RGD:6480464 |
CTD |
| G |
Il5 |
interleukin 5 |
|
multiple interactions |
ISO |
10 |
39,177,786 |
39,180,657 |
RGD:6480464 |
CTD |
| G |
Il5ra |
interleukin 5 receptor, alpha |
|
multiple interactions |
ISO |
4 |
142,067,108 |
142,098,051 |
RGD:6480464 |
CTD |
| G |
Il5ra |
interleukin 5 receptor, alpha |
|
decreases expression |
ISO |
4 |
142,067,108 |
142,098,051 |
RGD:6480464 |
CTD |
| G |
Il5ra |
interleukin 5 receptor, alpha |
|
decreases expression |
ISO |
4 |
142,067,108 |
142,098,051 |
RGD:6480464 |
CTD |
| G |
Il5ra |
interleukin 5 receptor, alpha |
|
decreases expression |
ISO |
4 |
142,067,108 |
142,098,051 |
RGD:6480464 |
CTD |
| G |
Il5ra |
interleukin 5 receptor, alpha |
|
increases expression |
ISO |
4 |
142,067,108 |
142,098,051 |
RGD:6480464 |
CTD |
| G |
Il5ra |
interleukin 5 receptor, alpha |
|
multiple interactions |
EXP |
4 |
142,067,108 |
142,098,051 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
decreases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
decreases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
decreases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Ilf3 |
interleukin enhancer binding factor 3 |
|
decreases expression |
ISO |
8 |
20,481,746 |
20,508,850 |
RGD:6480464 |
CTD |
| G |
Ilkap |
integrin-linked kinase-associated serine/threonine phosphatase |
|
decreases expression |
ISO |
9 |
90,602,949 |
90,626,753 |
RGD:6480464 |
CTD |
| G |
Impdh2 |
IMP (inosine 5'-monophosphate) dehydrogenase 2 |
|
increases expression |
ISO |
8 |
113,607,025 |
113,611,613 |
RGD:6480464 |
CTD |
| G |
Ina |
internexin neuronal intermediate filament protein, alpha |
|
decreases expression |
ISO |
1 |
252,328,186 |
252,340,997 |
RGD:6480464 |
CTD |
| G |
Inhbc |
inhibin beta C |
|
decreases expression |
ISO |
7 |
67,315,295 |
67,328,764 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
increases expression |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
increases secretion |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Irf1 |
interferon regulatory factor 1 |
|
multiple interactions |
ISO |
10 |
39,220,600 |
39,227,602 |
RGD:6480464 |
CTD |
| G |
Irf1 |
interferon regulatory factor 1 |
|
multiple interactions |
ISO |
10 |
39,220,600 |
39,227,602 |
RGD:6480464 |
CTD |
| G |
Irf1 |
interferon regulatory factor 1 |
|
multiple interactions |
ISO |
10 |
39,220,600 |
39,227,602 |
RGD:6480464 |
CTD |
| G |
Irf1 |
interferon regulatory factor 1 |
|
multiple interactions |
ISO |
10 |
39,220,600 |
39,227,602 |
RGD:6480464 |
CTD |
| G |
Itgb2 |
integrin, beta 2 |
|
increases expression |
ISO |
20 |
11,446,521 |
11,485,009 |
RGD:6480464 |
CTD |
| G |
Itgb2 |
integrin, beta 2 |
|
increases expression |
ISO |
20 |
11,446,521 |
11,485,009 |
RGD:6480464 |
CTD |
| G |
Itgb7 |
integrin, beta 7 |
|
increases expression |
ISO |
7 |
140,971,310 |
140,984,091 |
RGD:6480464 |
CTD |
| G |
Itm2b |
integral membrane protein 2B |
|
decreases expression |
ISO |
15 |
54,005,134 |
54,028,036 |
RGD:6480464 |
CTD |
| G |
Itm2b |
integral membrane protein 2B |
|
increases expression |
ISO |
15 |
54,005,134 |
54,028,036 |
RGD:6480464 |
CTD |
| G |
Itpka |
inositol-trisphosphate 3-kinase A |
|
decreases expression |
ISO |
3 |
106,257,482 |
106,266,160 |
RGD:6480464 |
CTD |
| G |
Ivl |
involucrin |
|
multiple interactions |
ISO |
2 |
185,556,271 |
185,558,310 |
RGD:6480464 |
CTD |
| G |
Ivl |
involucrin |
|
decreases expression |
ISO |
2 |
185,556,271 |
185,558,310 |
RGD:6480464 |
CTD |
| G |
Ivl |
involucrin |
|
increases expression |
ISO |
2 |
185,556,271 |
185,558,310 |
RGD:6480464 |
CTD |
| G |
Ivl |
involucrin |
|
increases expression |
ISO |
2 |
185,556,271 |
185,558,310 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
decreases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
decreases phosphorylation |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases phosphorylation |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
affects expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
decreases expression |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Junb |
jun B proto-oncogene |
|
increases expression |
ISO |
19 |
24,831,536 |
24,833,320 |
RGD:6480464 |
CTD |
| G |
Jund |
jun D proto-oncogene |
|
increases expression |
ISO |
16 |
19,239,694 |
19,241,529 |
RGD:6480464 |
CTD |
| G |
Jund |
jun D proto-oncogene |
|
increases expression |
ISO |
16 |
19,239,694 |
19,241,529 |
RGD:6480464 |
CTD |
| G |
Kcnb1 |
potassium voltage gated channel, Shab-related subfamily, member 1 |
|
multiple interactions |
ISO |
3 |
158,250,001 |
158,345,927 |
RGD:6480464 |
CTD |
| G |
Kdelr3 |
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 3 |
|
increases expression |
ISO |
7 |
117,556,569 |
117,566,504 |
RGD:6480464 |
CTD |
| G |
Kdm1a |
lysine (K)-specific demethylase 1A |
|
affects localization |
ISO |
5 |
155,299,289 |
155,358,404 |
RGD:6480464 |
CTD |
| G |
Kdm5b |
lysine (K)-specific demethylase 5B |
|
decreases expression |
ISO |
13 |
47,502,602 |
47,576,946 |
RGD:6480464 |
CTD |
| G |
Kdr |
kinase insert domain receptor |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Khk |
ketohexokinase |
|
decreases expression |
ISO |
6 |
25,428,263 |
25,438,497 |
RGD:6480464 |
CTD |
| G |
Kif22 |
kinesin family member 22 |
|
decreases expression |
ISO |
1 |
186,205,162 |
186,293,437 |
RGD:6480464 |
CTD |
| G |
Kif2c |
kinesin family member 2C |
|
decreases expression |
ISO |
5 |
137,473,698 |
137,498,974 |
RGD:6480464 |
CTD |
| G |
Kit |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
decreases activity |
ISO |
14 |
34,906,043 |
34,984,819 |
RGD:6480464 |
CTD |
| G |
Kit |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
increases expression |
ISO |
14 |
34,906,043 |
34,984,819 |
RGD:6480464 |
CTD |
| G |
Kit |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
increases expression |
EXP |
14 |
34,906,043 |
34,984,819 |
RGD:6480464 |
CTD |
| G |
Kitlg |
KIT ligand |
|
increases expression |
ISO |
7 |
37,714,157 |
37,795,722 |
RGD:6480464 |
CTD |
| G |
Kitlg |
KIT ligand |
|
multiple interactions |
ISO |
7 |
37,714,157 |
37,795,722 |
RGD:6480464 |
CTD |
| G |
Klf13 |
Kruppel-like factor 13 |
|
decreases expression |
ISO |
1 |
118,368,164 |
118,398,938 |
RGD:6480464 |
CTD |
| G |
Klf4 |
Kruppel-like factor 4 (gut) |
|
increases expression |
ISO |
5 |
73,446,928 |
73,451,286 |
RGD:6480464 |
CTD |
| G |
Klf9 |
Kruppel-like factor 9 |
|
decreases expression |
ISO |
1 |
226,420,949 |
226,446,376 |
RGD:6480464 |
CTD |
| G |
Klk10 |
kallikrein related-peptidase 10 |
|
increases expression |
ISO |
1 |
94,210,924 |
94,214,301 |
RGD:6480464 |
CTD |
| G |
Klk13 |
kallikrein related-peptidase 13 |
|
increases expression |
ISO |
1 |
94,133,589 |
94,145,208 |
RGD:6480464 |
CTD |
| G |
Klk7 |
kallikrein-related peptidase 7 |
|
increases expression |
ISO |
1 |
94,243,421 |
94,246,711 |
RGD:6480464 |
CTD |
| G |
Klrg1 |
killer cell lectin-like receptor subfamily G, member 1 |
|
decreases expression |
ISO |
4 |
158,673,698 |
158,684,674 |
RGD:6480464 |
CTD |
| G |
Kpna1 |
karyopherin alpha 1 |
|
increases expression |
ISO |
11 |
66,555,859 |
66,595,898 |
RGD:6480464 |
CTD |
| G |
Kpna2 |
karyopherin alpha 2 |
|
decreases expression |
ISO |
10 |
96,342,214 |
96,352,613 |
RGD:6480464 |
CTD |
| G |
Kpnb1 |
karyopherin (importin) beta 1 |
|
decreases expression |
ISO |
10 |
85,882,382 |
85,910,805 |
RGD:6480464 |
CTD |
| G |
Krt1 |
keratin 1 |
|
increases expression |
ISO |
7 |
140,540,960 |
140,546,186 |
RGD:6480464 |
CTD |
| G |
Krt1 |
keratin 1 |
|
increases expression |
ISO |
7 |
140,540,960 |
140,546,186 |
RGD:6480464 |
CTD |
| G |
Krt1 |
keratin 1 |
|
decreases expression |
ISO |
7 |
140,540,960 |
140,546,186 |
RGD:6480464 |
CTD |
| G |
Krt10 |
keratin 10 |
|
decreases expression |
ISO |
10 |
88,288,620 |
88,292,615 |
RGD:6480464 |
CTD |
| G |
Krt10 |
keratin 10 |
|
increases expression |
ISO |
10 |
88,288,620 |
88,292,615 |
RGD:6480464 |
CTD |
| G |
Krt10 |
keratin 10 |
|
increases expression |
ISO |
10 |
88,288,620 |
88,292,615 |
RGD:6480464 |
CTD |
| G |
Krt14 |
keratin 14 |
|
decreases expression |
ISO |
10 |
89,144,357 |
89,148,415 |
RGD:6480464 |
CTD |
| G |
Krt14 |
keratin 14 |
|
increases expression |
ISO |
10 |
89,144,357 |
89,148,415 |
RGD:6480464 |
CTD |
| G |
Krt15 |
keratin 15 |
|
increases expression |
ISO |
10 |
89,071,915 |
89,075,732 |
RGD:6480464 |
CTD |
| G |
Krt17 |
keratin 17 |
|
increases expression |
ISO |
10 |
89,185,097 |
89,189,816 |
RGD:6480464 |
CTD |
| G |
Krt17 |
keratin 17 |
|
decreases expression |
ISO |
10 |
89,185,097 |
89,189,816 |
RGD:6480464 |
CTD |
| G |
Krt17 |
keratin 17 |
|
decreases expression |
ISO |
10 |
89,185,097 |
89,189,816 |
RGD:6480464 |
CTD |
| G |
Krt18 |
keratin 18 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Krt18 |
keratin 18 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Krt18 |
keratin 18 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Krt19 |
keratin 19 |
|
increases expression |
ISO |
10 |
89,080,953 |
89,085,670 |
RGD:6480464 |
CTD |
| G |
Krt19 |
keratin 19 |
|
increases expression |
ISO |
10 |
89,080,953 |
89,085,670 |
RGD:6480464 |
CTD |
| G |
Krt19 |
keratin 19 |
|
increases expression |
ISO |
10 |
89,080,953 |
89,085,670 |
RGD:6480464 |
CTD |
| G |
Krt2 |
keratin 2 |
|
increases expression |
ISO |
7 |
140,500,902 |
140,507,590 |
RGD:6480464 |
CTD |
| G |
Krt23 |
keratin 23 (histone deacetylase inducible) |
|
increases expression |
ISO |
10 |
88,420,780 |
88,436,791 |
RGD:6480464 |
CTD |
| G |
Krt4 |
keratin 4 |
|
increases expression |
ISO |
7 |
140,622,632 |
140,628,079 |
RGD:6480464 |
CTD |
| G |
Krt5 |
keratin 5 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Krt7 |
keratin 7 |
|
increases expression |
ISO |
7 |
140,160,829 |
140,226,474 |
RGD:6480464 |
CTD |
| G |
Krt7 |
keratin 7 |
|
increases expression |
ISO |
7 |
140,160,829 |
140,226,474 |
RGD:6480464 |
CTD |
| G |
Krt75 |
keratin 75 |
|
decreases expression |
ISO |
7 |
140,320,625 |
140,329,260 |
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
increases expression |
ISO |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
increases expression |
ISO |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
increases expression |
ISO |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
Kynu |
kynureninase |
|
increases expression |
ISO |
3 |
24,046,242 |
24,195,898 |
RGD:6480464 |
CTD |
| G |
Lama1 |
laminin, alpha 1 |
|
increases expression |
ISO |
9 |
106,855,708 |
106,980,651 |
RGD:6480464 |
CTD |
| G |
Lama2 |
laminin, alpha 2 |
|
decreases expression |
ISO |
1 |
18,203,466 |
18,885,462 |
RGD:6480464 |
CTD |
| G |
Lama2 |
laminin, alpha 2 |
|
decreases expression |
ISO |
1 |
18,203,466 |
18,885,462 |
RGD:6480464 |
CTD |
| G |
Lama3 |
laminin, alpha 3 |
|
decreases expression |
ISO |
18 |
4,030,463 |
4,121,355 |
RGD:6480464 |
CTD |
| G |
Lama5 |
laminin, alpha 5 |
|
increases expression |
ISO |
3 |
169,233,897 |
169,282,410 |
RGD:6480464 |
CTD |
| G |
Lamb1 |
laminin, beta 1 |
|
increases expression |
ISO |
6 |
49,115,671 |
49,183,374 |
RGD:6480464 |
CTD |
| G |
Lamb1 |
laminin, beta 1 |
|
increases expression |
ISO |
6 |
49,115,671 |
49,183,374 |
RGD:6480464 |
CTD |
| G |
Ly6g6e |
lymphocyte antigen 6 complex, locus G6E |
|
decreases expression |
ISO |
20 |
3,808,707 |
3,810,443 |
RGD:6480464 |
CTD |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
increases expression |
ISO |
5 |
16,933,111 |
17,054,564 |
RGD:6480464 |
CTD |
| G |
Mad1l1 |
MAD1 mitotic arrest deficient-like 1 (yeast) |
|
decreases expression |
ISO |
12 |
14,793,899 |
15,107,476 |
RGD:6480464 |
CTD |
| G |
Maf |
v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian) |
|
increases expression |
ISO |
19 |
45,859,510 |
45,861,454 |
RGD:6480464 |
CTD |
| G |
Magoh |
mago-nashi homolog, proliferation-associated (Drosophila) |
|
decreases expression |
ISO |
5 |
128,982,276 |
128,989,724 |
RGD:6480464 |
CTD |
| G |
Manea |
mannosidase, endo-alpha |
|
affects expression |
ISO |
5 |
41,577,651 |
41,590,456 |
RGD:6480464 |
CTD |
| G |
Map2 |
microtubule-associated protein 2 |
|
multiple interactions |
ISO |
9 |
65,174,376 |
65,256,003 |
RGD:6480464 |
CTD |
| G |
Map2 |
microtubule-associated protein 2 |
|
increases expression |
ISO |
9 |
65,174,376 |
65,256,003 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
multiple interactions |
ISO |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
decreases expression |
ISO |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Map3k4 |
mitogen activated protein kinase kinase kinase 4 |
|
decreases expression |
ISO |
1 |
42,891,172 |
42,978,862 |
RGD:6480464 |
CTD |
| G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
|
decreases expression |
ISO |
1 |
15,205,361 |
15,346,422 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
decreases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Npepo |
aminopeptidase O |
|
increases expression |
ISO |
17 |
7,353,426 |
7,624,936 |
RGD:6480464 |
CTD |
| G |
RGD1308750 |
similar to DNA segment, Chr 19, Brigham & Womens Genetics 1357 expressed |
|
decreases expression |
ISO |
X |
157,318,025 |
157,319,968 |
RGD:6480464 |
CTD |
| G |
RGD1561149 |
similar to mKIAA1522 protein |
|
decreases expression |
ISO |
5 |
148,379,359 |
148,387,824 |
RGD:6480464 |
CTD |
| G |
RGD1563692 |
similar to hypothetical protein FLJ22671 |
|
increases expression |
ISO |
9 |
92,427,931 |
92,437,438 |
RGD:6480464 |
CTD |
| G |
RT1-DMa |
RT1 class II, locus DMa |
|
increases expression |
ISO |
20 |
4,843,458 |
4,846,861 |
RGD:6480464 |
CTD |
Term paths to the root
|